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PRRT2 is a single causative gene for paroxysmal kinesigenic dyskinesia disease. 
Several studies have identified an array of heterozygous loss-of-function 
nonsense/frameshift and missense mutations in the gene encoding this protein 
that through non-sense mediated RNA decay and/or degradation of 
truncated/misfolded protein cause a condition of haploinsufficiency. 
These mutations are described in a large number of patients affected by 
paroxysmal disorders such as benign familial infantile seizures, infantile 
convulsion choreoathetosis, migraine, hemiplegic migraine, paroxysmal 
kinesigenic dyskinesia/choreoathetosis, benign familial infantile 
seizures/epilepsy, and episodic ataxia. 
PRRT2 is a small gene located on chromosome 16p11.2 already expressed at 
early postnatal stages, and its expression increases till reaching a plateau at 1 
month of life; high levels of PRRT2 mRNA were detected in many tissues of the 
nervous system, especially in the extrapyramidal system. 
We have previously shown that PRRT2 is a key component of regulated 
exocytosis and its silencing dramatically impairs neurotransmitter release by 
markedly reducing release probability. Moreover, we demonstrated that PRRT2 
interacts with the fast Ca2+ sensors synaptotagmin 1/2 and endows the SNARE 
complex with Ca2+ sensitivity. Here, we investigated the altered Ca2+ dependence 
of glutamatergic synaptic transmission as a possible causative role in the 
pathogenesis of PRRT2-linked paroxysmal diseases by focusing on voltage-gated 
Ca2+channels (VGCaCh) and presynaptic Ca2+ influx. 
Thanks to the use of multiple experimental approaches, including 
electrophysiology, immunocytochemistry, biochemistry and live Ca2+ imaging, we 
investigated the changes of somatic and presynaptic VGCaCh subtypes in PRRT2-
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deficient neurons but also the altered Ca2+ dependence of the synaptic 
transmission. 
We observed that PRRT2 deletion induces a significant decrease in the amplitude 
of evoked excitatory synaptic currents (eESPCs) recorded at increasing 
concentrations of extracellular Ca2+. This effect was associated with a reduction 
of P/Q- and N-type VGCa currents paralleled by a decrease in the amplitude of N- 
and P/Q-type sensitive eESPCs.  
Using surface biotinylation, we observed that PRRT2 deletion impaired the P/Q-
type VGCaChs trafficking to the membrane. Double immunostainings revealed 
that in presynaptic terminals lacking PRRT2, the P/Q-type VGCaChs diffused in 
the presynaptic membrane and reduce their clustering at the active zone. In 
parallel, using SyGCaMP-6s, an ultra-sensitive fluorescent Ca2+ indicator 
selectively expressed at the presynapse, we investigated presynaptic Ca2+ influx 
and observed a significant decrease of the P/Q-dependent presynaptic Ca2+ 
signal in PRRT2-deficient synapses. 
 
Our results strongly suggest that PRRT2 deletion causes mistargeting of P/Q-type 
VGCaChs far away from the active zone, reducing the availability of VGCaCh 
strictly associated with the release machinery and thereby the glutamate release 
probability. 
Altogether our data highlights the central role of PRRT2 in the release machinery, 
indeed, the lack of this protein impaired the N- and P/Q-type channels trafficking 
from the cytoplasm to the membrane causing of a reduction of intracellular Ca2+ 





1.1 The Pathology: Paroxysmal Kinesigenic Dyskinesia (PKD) 
Paroxysmal kinesigenic dyskinesia (PKD) was first described in 1967 and is now 
recognized as the most common type of paroxysmal movement disorder 
(Kertesz, A. 1967). This disease is characterized by recurrent, brief attacks of 
dyskinesia that are triggered by sudden voluntary movement (Goodenough et al., 
1978). The episodes usually present with dystonia, chorea, athetosis, ballism or 
their combination. The attacks usually last from a few seconds to a few minutes. 
During the attacks, there is absolutely no loss or alteration of consciousness. 
However, the prognosis of PKD is favorable and the patients usually show 
excellent responses to antiepileptic drugs (Kertesz, 1967; Goodenough et al., 
1978; Houser et al., 1999; Lotze and Jankovic, 2003; Bruno et al., 2004).  
Onset age in PKD varies between 6 months and 33 years, but more frequently 
between 7 and 15 years. A higher prevalence of the sporadic form was observed 
in males (4:1, even up to 8:1), but not in familial cases. Typically, an attack is 
induced by a sudden movement, for example, getting up quickly to answer the 
doorbell or the telephone. However, even a sudden increase in speed, 
amplitude, or strength of the movements or even the sudden addition of new 
actions during ongoing steady movements may induce an attack (Fahn S. 1994; 
Bhatia KP. 2001; Demirkiran M. et al., 1995). An example of this may be the 
sudden acceleration from a walk to a run (trying to catch a bus) or a sudden 
change in direction. Startle, sound and photo stimulation, vestibular stimulation, 
hyperventilation, or stress may also trigger attacks (Bhatia, 2011). For these 
reasons PKD attacks are frequent.  
Typically, attacks affect limbs on one side, although generalized attacks also can 
occur. About 30% of the patients experienced speech disturbance (dysarthria or 
anarthria) that may be the result of face involvement (Houser et al., 1999). In 
case of multiple attacks, there may be a refractory period of about 20 minutes 
during which no further attacks can be induced (Lishman et al., 1962). The most 
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of the attacks are very brief, lasting only seconds (Houser et al., 1999; Bruno et 
al., 2004). Houser et and colleagues (1999) reported that,   attacks lasted less 
than 2 minutes in 88% of cases and between 30 and 60 seconds in two thirds of 
patients. Similarly, Bruno et al. (2004) reported that attacks were shorter than 1 
minute in 95% of patients. Long PKD-like attacks should thus make the clinician 
suspicious of a secondary cause, including the possibility of psychogenic 
paroxysmal disorder.  
Most patients have 1–20 attacks per day, whereas some patients may also have 
more than 20 attacks per day. However, the frequency of PKD episodes usually 
peaks in puberty with up to 30–100 attacks and then becomes less after age 20 
and may even completely remit after age 30 (Bruno et al., 2004). 
Because the paroxysmal movements are regarded as an epileptic manifestation, 
paroxysmal kinesigenic dyskinesia is often misdiagnosed as epilepsy. Among the 
primary forms, 65%–72% of PKD patients have a family history of a similar 
disorder with an autosomal dominant inheritance. Identification of the genes  
underling the pathogenesis has enhanced diagnosis and clarified the mechanisms 
of disease progression in paroxysmal kinesigenic dyskinesia.  
Chen et al. (2011) first reported PRRT2 mutations as the genetic cause of PKD in 
eight families with PKD, opening the way to the identification of PRRT2 mutation 
in several clinical syndromes previously associated with PKD such as the so-called 
infantile convulsions with choreoathetosis (ICCA) syndrome and benign familial 
infantile seizure syndrome (Ebrahimi-Fakhari D, et al. 2015). Very quickly, a 
strong interest about this gene suddenly increased, in particular thanks to the 
next-generation sequencing, combined with classic linkage analysis, that allowed 
the identification of an array of PRRT2 mutations as the leading cause of the 
most common type of familial paroxysmal movement disorder, paroxysmal 
kinesigenic dyskinesia (PKD) (Chen et al. 2011; Wang et al., 2011). 
In few years, several studies have identified an array of heterozygous nonsense, 
frameshift, and missense mutations in the gene encoding proline-rich 
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transmembrane protein 2 (PRRT2) in a large number of cases affected by 
different paroxysmal disorders such as benign familial infantile seizures, infantile 
convulsion choreoathetosis, migraine, hemiplegic migraine, paroxysmal 
kinesigenic dyskinesia/choreoathetosis, benign familial infantile 
seizures/epilepsy, and episodic ataxia (Chen et al., 2011; Lee et al., 2012; Valente 
et al., 2016). Currently, PRRT2 is the major gene accounting for PKD, with a 
frequency ranging from about 40% to over 90%, depending on case 
ascertainment (Ebrahimi-Fakhari D, et al. 2015; Erro R., et al. 2017). 
2. The PRRT2 Gene 
 
Paroxysmal Kinesigenic dyskinesia Dyskinesia  (PKD) is most commonly 
transmitted in an autosomal dominant mode of inheritance (Bruno et al., 2004). 
The causative role of PRRT2 mutations in the pathogenesis of PKD and of a 
variety of additional paroxysmal disorders with a similar pattern of inheritance is 
now documented by extensive studies and summarized by recent 
comprehensive reviews (Wood H. 2012; Heron, S.E. and Dibbens, L.M.,2013; 
Ebrahimi-Fakhari, D. et al., 2015). Interestingly, all PRRT2-associated disorders 
appear paroxysmal in nature, suggesting the presence of shared 
pathophysiological mechanisms. In contrast, other common non-paroxysmal 
movement disorders, such as Parkinson's disease, are not associated with PRRT2 
mutations (Kumar et al., 2012). The astonishing pleiotropy of the phenotypic 
expression of PRRT2 mutations points to an overlap in the pathogenic pathways 
and to a very important role of this gene in regulating synaptic transmission and 
network activity. Several linkage studies have identified two regions on 
chromosome 16 (16p11.2–q12.1 and 16q13–q22.1) that are likely to harbor 
paroxysmal kinesigenic dyskinesia susceptibility genes in populations of diverse 
ancestry (Tomita, H. et al., 1999; Swoboda, K.J. et al., 2000; Bennett, L.B., et al., 
2000; Valente, E.M.et al., 2000).  
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PRRT2 is a small gene located on chromosome 16p11.2 and containing four 
exons, the first of which is noncoding. The main encoded isoform of PRRT2 is a 
340 amino acid protein (Chen et al., 2011), highly conserved (~80%) among 
mammals, with some similarity (~30%) still appreciable in lower vertebrates (e.g., 
zebrafish). Sequence conservation is particularly prominent (up to 90% in 
mammals and 60% in zebrafish) in the C-terminal region of the molecule, which 
includes two hydrophobic helices (M1 and M2) separated by a short polar amino 
acid sequence and followed by a two-residue C terminus (Lee et al., 2012). The 
PRRT2 gene contains four exons, with exons 2–4 encoding a multidomain protein 
of 340 amino acids formed by a long N-terminal domain (1–268) containing a 
proline-rich region (PRD); two putative transmembrane helices, M1 (269–289) 
and M2 (318–338), separated by an intracellular loop (CYT, 290–317), and a C-
terminal dipeptide (339–340)(Figure 1). Despite the similarity with the proteins 
of the dispanin family, only M2 is a true transmembrane helix, while M1 is folded 
into two halves (M1a and M1b) by a hinge formed by two proline residues. As a 
consequence, M1 does not cross the membrane. Due to its single 
transmembrane domain, PRRT2 exposes the long N- terminal domain and the 
short M1–M2 loop to the cytoplasm and maintains a C-terminal anchor, 
conforming the model of a type II transmembrane protein (Valtorta et al., 2016; 
Rossi et al., 2016). In a study of the expression profile of PRRT2, high levels of 
PRRT2 mRNA were detected in many tissues of the nervous system, especially in 
the extrapyramidal system, which includes the globus pallidus, cerebellum, 
subthalamic nucleus, cerebellar peduncles and caudate nucleus (Su A.I., et al, 
2004; Chen et al., 2011; Lee et al., 2012; Heron et al., 2012; Trabzuni et al., 
2011). The PRRT2 gene was already expressed at early postnatal stages, and its 
expression increased to reach a plateau at 1 month of life, a period of intense 
synapse formation and rearrangement. The same pattern was reproduced in 
primary hippocampal and cortical neurons, where PRRT2 expression, already 
discernible at early stages, was greatly enhanced between 10 and 21 days in vitro 
(DIVs), a temporal window of intense synaptogenesis (Valente et al 2016). 
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However, there are no reports of the function of the PRRT2 protein or the 
relationship between PRRT2 and neurological disorders. The functional role of 
this protein is totally unknown. A yeast two- hybrid screen highlighted a 
potential interaction of PRRT2 with synaptosomal-associated protein 25 kDa 
(SNAP-25), one of the presynaptic soluble N-ethylmaleimide sensitive factor 
(NSF) attachment protein receptor (SNARE) proteins triggering fusion of synaptic 
vesicles (SVs) (Stelzl et al., 2005; Lee et al., 2012). Recently, PRRT2 has also been 
found among proteins associated with a-amino-3-hydroxy-5-methyl-4-
isoxazolepro-pionic acid (AMPA)-type glutamate receptors by a high-resolution 
proteomics study (Schwenk et al., 2014), and its mutation was associated with 
increased levels of extracellular glutamate (Li et al., 2015). 
 
 
Figure 1. PRRT2 protein domain structure. The PRRT2 gene contains four exons that encode several domains in the PRRT2 protein, 
including two extracellular domains, two transmembrane domains and one cytoplasmic domain. The proline-rich domain overlaps with the 










2.1 PRRT2 Mutations 
 
Most mutations identified in PRRT2 are phenotypically highly penetrant and 
cause truncation of the protein because of nonsense or frameshifts mutations 
that result in mRNA degradation by nonsense-mediated mRNA decay or 
degradation of the protein (Wu et al., 2014), suggesting a loss- of-function 
mechanism of action. In spite of the numerous mutations described so far 
(Figure 2; Heron, S.E. and Dibbens, L.M.,2013; Cloarec, R. et al., 2012; Lee et al., 
2012), no specific genotype–phenotype correlations have emerged. A common 
c.649dupC frameshift mutation segregates in about 80% of the PRRT2 mutant 
families, resulting in diverse paroxysmal disorders (Ebrahimi-Fakhari et al., 2015). 
Family members carrying identical PRRT2 mutations often exhibit variable 
phenotypes, with each of them suffering from a different disease (Brueckner, F. 
et al. (2014). The phenotype may vary even with different ages of the same 
individual (in PKD/IC an individual may present with infantile seizures that remit 
during infancy, and subsequently develop PKD during adolescence). These 
remarkably pleiotropic effects imply that genetic buffering as well as factors 
other than the mutations in PRRT2 influence expression of the disease. A vast 
majority of PRRT2 mutations reported (about 95%) are nonsense or frameshift 
(Figure 2; Liu et al., 2013). Among these mutations, a common frameshift 
mutation occurs in an unstable region of nine cytosines (c.641-c.649), causing 
the introduction of a stop codon seven AAs downstream of insertion (c.649-
650insC>p.Arg217Profs*7) (Lee et al., 2012). The c.649dupC frameshift mutation 
leads to an unstable mRNA or a truncated form of the protein that is degraded, 
resulting in a loss-of-function pathogenetic mechanism (Lee et al., 2012; Li et al., 
2015; Liu et al., 2016). 
A variety of other nonsense or frameshift mutations are mostly located in the 
long N-terminal domain of the protein (figure 2), scattered in the proline-rich 
domain, and only a few involve the transmembrane domains or the cytoplasmic 
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loop (Heron et al., 2012). In addition to these truncated mutants, a few missense 
mutations were also identified (Gardiner et al., 2012). 
 
Figure 2. Mapping of PRRT2 Mutations Superimposed to the Domain Structure of Proline-Rich Transmem- brane Protein (PRRT2) Protein. 
Mutations in PRRT2 have been recently identified as the cause for a heterogeneous group of paroxysmal neurological diseases. The 
identified nonsense/frameshift and missense mutations are reported on the PRRT2 domain structure in the upper and lower panels, 
respectively. (Valtorta et al., 2016) 
A recent discovery has identified heterozygous mutations in PRRT2, which 
encodes proline-rich transmembrane protein 2, in most families affected by 
benign familial infantile seizures (BFIS) (Heron et al., 2012). PRRT2 is also the 
major causative gene for familial paroxysmal kinesigenic dystonia (PKD) (Chen et 
al., 2011), a rare disorder characterized by the episodic occurrence of involuntary 
attacks of choreoathetosis or dystonia. Moreover, these studies illustrated that 
in a given family both disorders may be variably co-inherited as a single trait 
(Heron et al., 2012), corroborating the existence of familial infantile convulsions 
with paroxysmal choreoathetosis (ICCA) (Szepetowski et al., 1997). More 
recently, other paroxysmal neurological manifestations have been reported in 
heterozygous patients: paroxysmal non-kinesigenic dyskinesia (PNKD), migraine 
with or without aura, hemiplaegic migraine, various type of non-infantile 
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seizures, torticollis and episodic ataxia (EA; Méneret A, et al., 2013) Previous 
reports of three patients suggested that homozygous PRRT2 mutations may give 
rise to more severe clinical disease of mental retardation, with or without EA and 
epilepsy (Najmabadi H, et al., 2011; Labate A, et al., 2012). In addition, a 
recurrent genomic deletion of about 600 kb at 16p11.2, and encompassing 
several genes including PRRT2, has been associated with a composite syndromic 
phenotype displaying dysmorphisms, macrocephaly, speech/language delay, 
cognitive impairment, and a range of neuropsychiatric conditions including 
autistic spectrum disorder and intellectual disability, with or without paroxysmal 
disorders (Figure 3; Shinawi, M. et al., 2010; Weiss, L.A. et al., 2008). The dosage 
unbalance of multiple genes may have an additive or multiplicative effect on the 
phenotype and the role of specific genes–including PRRT2–is largely unknown. 
 
 
Figura 3. Clinical spectrum of PRRT2 mutations. The large green arrows point to phenotypes predominantly caused by PRRT2 mutations 
[paroxysmal kinesigenic dyskinesia (PKD), infantile convulsions with choreoathetosis syndrome ICCA), benign familial infantile seizures 
(BFIS)]. The thin pink arrows point to phenotypes rarely induced by PRRT2 mutations [paroxysmal non-kinesigenic dyskinesia (PNKD), 
paroxysmal exerciseinduced dyskinesia (PED), hemiplegic migraine (HM), episodic ataxia (EA), febrile seizures (FS), childhood-absence 





2.2 PRRT2 Expression and Localization 
 
The dominant effect of PRRT2 mutations associated with diverse paroxysmal 
disorders points to an important role of the protein in neuronal activity. PRRT2 
expression was prominent throughout the adult brain, with the highest levels in 
the cerebellum, basal ganglia, and neocortex. In the cerebral cortex and 
hippocampus, the PRRT2 gene was already expressed at early postnatal stages, 
and its expression increased to reach a plateau at 1 month of life, a period of 
intense synapse formation and rearrangement (Valente et al., 2016). In contrast, 
PRRT2 expression is almost undetectable in primary astroglial cultures, consis- 
tent with the neuron-specific expression of PRRT2. To explore the expression 
pattern of PRRT2 in vivo, in Chen et al. (2011) they measured the levels of PRRT2 
mRNA in various body tissues of mice by RT-PCR. At postnatal day 7 (P7), PRRT2 
was detected at low levels in the heart, lung, kidney and skin, but was most 
highly expressed in the brain and spinal cord. From the examination of the 
temporal expression pattern of PRRT2 in the developing mouse brain they reveal 
that the levels of PRRT2 mRNA are relatively low before embryonic day 16 (E16) 
and are markedly increased during early postnatal stages. PRRT2 mRNA levels 
peaked at P14 and then declined to a relatively low level in adulthood. RT-PCR 
and in situ hybridization analyses of P14 mouse brain revealed that PRRT2 is 
expressed throughout the developing brain, with high levels present in the 
cerebral cortex, hippocampus and cerebellum, and expression is enriched in 
cortical layers of the cerebral cortex, as well as in granule cells and Purkinje cell 
layers of the cerebellum. PRRT2 was enriched in the synaptic membrane fraction 
(LP1), but was also detected in synaptic vesicle (LP2) and postsynaptic density 
(PSDI) fractions, indicating the presence of PRRT2 at both pre- and post-synaptic 
membranes (Liu et al., 2016). To verify the subcellular distribution of PRRT2 at 
the synapse, in Valente et al. (2016) they fractionated purified synaptosomes to 
isolate synaptic junctions, subsequently separated into active zone (AZ), 
postsynaptic density (PSD), and a fraction including extrinsic and integral 
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membrane proteins associated with the presynaptic area (non- synaptic 
synaptosomal protein [NSSP]) (Phillips et al., 2001). PRRT2 was enriched in the 
NSSP fraction, like SNAP-25 and synaptophysin. Although the protein appeared 
to be substantially absent from the PSD, low levels were associated with the AZ 
fraction.  
A yeast two-hybrid screen already revealed a potential interaction of PRRT2 in 
neural function with synaptosomal-associated protein of 25 kDa (SNAP25) (Stelzl 
U., et al., 2005), one of the three presynaptic SNARE proteins that govern SV 
exocytosis (Sudhof, T.C. and Rizo, J., 2011). Consistent with this observation, 
recombinant PRRT2 was found to distribute in the axons, with the highest 
concentration at synaptic contacts (Lee, H.Y., et al., 2012). The presynaptic 
localization of PRRT2 was confirmed by several groups (Heron, S.E., et al., 2013; 
Valente et al., 2016; Becker, F. et al., 2013; de Vries, B. et al.,2012; Luo, C. et al., 
2013). Upon subcellular fractionation of the mouse brain, we found that PRRT2 
co-distributed with SNAP25 and with proteins associated with the presynaptic 
area (Figure 4; Valente et al., 2016). Detectable levels of PRRT2 were also found 
in association with SVs. These results suggest that during the exo-endocytotic 
cycle of SVs, PRRT2 cycles between the presynaptic cytoplasm and the SV 
membrane, as shown for SNAP25. 
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Figure 4. Localization of PRRT2 in mature neurons. Primary hippocampal neurons transduced at 10 DIVs with PRRT2-mCherry (red) were 
subjected to immunostaining at 15 DIVs with antibodies to PRRT2, SNAP-25, and Syp1. PRRT2 immunoreactivity (red) largely overlapped 
with the staining of the two presynaptic proteins in axonal and nerve terminal areas. Scale bar, 10 mm. (Valente et al., 2016) 
 
PRRT2 was detected, albeit at very low levels, also in fractions enriched in 
postsynaptic densities (Valente et al., 2016; Liu, Y.T. et al., 2016). Thus, while its 
distribution indicates that PRRT2 is primarily a presynaptic protein, it is possible 
that it plays some role also in the postsynaptic compartment, in line with its 
putative interaction with the GluA1 subunit (GRIA) of the AMPA-type glutamate 
receptor complex, suggested on the basis of proteomic (Schwenk, J. et al., 2014; 
Shanks, N.F. et al., 2012) and co-immunoprecipitation (Li, M. et al., 2015) studies. 
Indeed, PRRT2 has been found to limit the membrane distribution of GRIA in the 
postsynaptic membrane (Li, M. et al., 2015), and PRRT2 immunoreactivity has 
been recently localized at the tip of dendritic spines (Liu, Y.T. et al., 2016). 
PRRT2 is transcribed and expressed selectively in neurons (Chen et al. 2011; 
Valente, Castroflorio et al. 2016). To investigate whether its expression is pan-
neuronal or restricted to specific neuronal populations, my colleagues have  
(Valente et al., 2019) performed double immunostaining of primary hippocampal 
neurons with antibodies against Ca2+/calmodulin-dependent protein kinase type 
II (CamKII) and glutamic acid decarboxylase-67 (GAD67) that specifically label 
glutamatergic and GABAergic neurons, respectively, and a polyclonal antibody 
raised against an N-terminal domain peptide of mouse PRRT2 (amino acids 1–
268; Liu et al. 2016; Figure 5 Upper panels), firstly tested in WT neurons. PRRT2 
was widely expressed in both excitatory and inhibitory neurons: not only the 
percentage of PRRT2-positive cells was approaching 100%, but also the 
immunoreactivity at the cell body level was quantitatively similar in both 
neuronal populations. Consistent with its neuron-specific expression, PRRT2 
staining was absent from GFAP-positive astrocytes in primary WT cultures (Figure 






Figure 5. Upper. Immunoreactivity for PRRT2 (green) in CamKII-positive excitatory neurons (upper row, red) and GAD67-positive inhibitory 
neurons (lower row, red) in hippocampal WT neurons at 17 DIV. Merge panels show the double-labeled neurons. Scale bar, 50 μm. Lower. 
Representative images of double immunostaining for PRRT2 and GFAP in WT primary hippocampal cultures at 17 DIV. GFAP-positive 
astrocytes (red) are devoid of specific PRRT2 staining that only decorates adjacent neurons. Scale bar: 20 μm.  (Valente et al., 2019) 
 
My research group have also investigated also in detail the PRRT2 distribution at 
the synaptic level by double immunostaining primary WT neurons for PRRT2 and 
either the vesicular glutamate transporter-1 (VGLUT1) or the vesicular GABA 
transporter (VGAT) to label excitatory and inhibitory synapses, respectively 
(Figure 6). When PRRT2 expression was analyzed at synaptic puncta in which the 
respective transporter and PRRT2 immunoreactivities were colocalized, PRRT2 
was more widely distributed in excitatory synapses (80.6 ± 1.5%) than in 
inhibitory synapses (47.4 ± 2.8%). Moreover, the analysis of the intensity of 
PRRT2 immunoreactivity at excitatory and inhibitory synaptic puncta revealed 
that PRRT2 was more intensely expressed in excitatory than in inhibitory 






Figure 6. Representative images of synaptic contacts from 17 DIV rat hippocampal neurons labeled with PRRT2 antibodies (green in the 
merge panel) and either the excitatory presynaptic marker VGLUT1 (red, left panel) or the inhibitory presynaptic marker VGAT (red, right 
panel). Merge panels identify synaptic puncta in which PRRT2 and the respective transporter colocalize (yellow) and that are reported 
below in the binary image (Col. points). (Valente et al., 2019)  
Silencing of PRRT2 induces extensive defects of synaptic structure and function. 
The most striking effect of acute silencing is a decreased number of synaptic 
contacts, observed in primary cultures (where it reaches 50%) as well as in vivo 
(Valente et al., 2016; Liu, Y.T. et al., 2016). There are also significant changes in 
the network connectivity. In primary PRRT2-KO hippocampal networks, the 
population of excitatory neurons was slightly increased and that of GABAergic 
neurons decreased with respect to WT cultures run in parallel. The PRRT2 
deletion acts on the density of synaptic connections. From the analysis of 
colocalization of synaptic puncta of a couple of specific pre- and postsynaptic 
markers such as VGLUT1/Homer-1 for glutamatergic synapses and 
VGAT/Gephyrin for GABAergic synapses, it has been found that the constitutive 
PRRT2 deletion decreased the density of excitatory synapses, while no significant 
changes were observed in the density of inhibitory connections (Valente et al., 
2019). 
The analysis of PRRT2-KO excitatory synapses by conventional transmission 
electron microscopy revealed a substantial preservation of the nerve terminal 
ultrastructure. Indeed, the density, diameter, clustering and spatial distribution 
of SVs in concentric shells from the AZ were unaffected by PRRT2 deletion, 
except for a significant increase in the number of SVs physically docked at the AZ 
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that was also previously observed after acute depletion of the protein (Valente, 
Castroflorio et al. 2016). 
Given that PRRT2 is localized at synaptic sites, in Valente et al., (2019) evaluated 
the expression of a panel of synaptic markers (Snap25, vGLUTs, SYTs, vGAT) using 
qRT-PCR in primary hippocampal neurons from WT and PRRT2-KO mice at 
various stages of in vitro development. The mRNA levels of all genes tested 
showed no significant differences between WT and PRRT2-KO neurons except for 
PRRT2 at any time point. 
3. PRRT2 is a Key Component of the Ca2+-Dependent 
Neurotransmitter Release Machinery 
 
The presynaptic distribution of PRRT2 indicates a potential role in 
neurotransmitter release. Such a role could be hindered by mutations of the 
gene, as documented by the phenotype of the PRRT2-related diseases. To dissect 
the effects of PRRT2 silencing, were investigated spontaneous release, 
stochastically occurring at resting [Ca2+] concentrations; evoked synchronous 
release, temporally bound to the action potential and the ensuing Ca2+ inflow at 
the active zone. To analyze how PRRT2 KD affects the function and strength of 
excitatory and inhibitory synapses and avoid the confounding effects of non-
transduced neurons, in Valente et al. (2016) it was used autaptic hippocampal 
neurons. 
These autaptic neurons was infected with a short hairpin RNAs (shRNA) with a 
fluorescence tag (turboGFP) that allowed to distinguish the PRRT2 silenced 
neurons (Sh4) from the Scramble (Scr) one and allowed to proceed to analyze: 1) 
synaptic density 2) spontaneous and 3) evoked synaptic transmission.  
Mature (14 DIVs) neurons was infected with either Sh4 at 7 DIVs and analyzed by 
counting synapse density. Valente et al. (2016) and colleagues identified Synaptic 
boutons by counting puncta with a size of <1 mm double-positive for pairs of 
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pre/postsynaptic proteins such as Bassoon/Homer1 or synaptophysin/PSD95. 
Strikingly, the density of excitatory synapses along dendrites was decreased by 
~50% in neurons silenced for PRRT2 with either shRNA, an effect that was fully 
rescued by the expression of shRNA-resistant PRRT2. This data confirmed the 
decrease in synapse density in the absence of major changes in the terminal 
ultrastructure (Figure 7). 
 
 
Figure 7. PRRT2 Knockdown Decreases Synapse Density. Upper. Representative images of dendrites of hippocampal neurons infected at 7 
DIVs with Scr, Sh4, and Sh4 + Sh4-resistant PRRT2 (Sh4+PRRT2) or left uninfected and analyzed at 14 DIVs. Synaptic boutons were identified 
by double immunostaining for Bassoon (Bsn, red) and Homer1 (green). The colocalization panels (Col. points) highlight the double-positive 
puncta (black) corresponding to synapses. Scale bar, 10 mm. Lower left. Quantitative analysis of synaptic puncta counted on 30-
mmdendrite tracts starting from the cell body in neurons treated as in upper figure. Data are means ± SEM from three independent 
experiments, each carried out in duplicate. Five dendrites for each neuron, from at least ten neurons for each sample, were counted. *p < 
0.05, one-way ANOVA/Bonferroni’s multiple comparison test. NI, not infected. Lower right. Quantitative analysis of the synaptic density 
from serial ultrathin sections. The volume density of symmetric and asymmetric synapses was calculated from the 2D count of synaptic 
profiles in sections from Sh4- (red bars) and Scr-treated (black bars) neurons and is expressed as mean (± SEM) number of synapses per 





Miniature excitatory postsynaptic currents (mEPSCs; Figure 8, upper) were 
continuously recorded at the soma of voltage-clamped neurons held at –70 mV 
in the presence of tetrodotoxin (TTX) to block spontaneous APs (Chiappalone et 
al., 2009). Strikingly, the mEPSC frequency (Figure 8, lower) fell down in PRRT2-
silenced cultures, an extent much larger than expected from the decrease in 
synapse density (Figure 8) observed in PRRT2-silenced autaptic excitatory 
neurons. A reduction of approximately the same extent was also observed in the 
mEPSC area and amplitude (Figure 8, lower). Such a change may be attributable 
to the corresponding reduction in the average SV volume, although concomitant 
postsynaptic effects cannot be excluded. 
 
 
Figure 8 Upper. Representative recording traces of mEPSCs from PRRT2-KD synapses (Sh4, red traces) and control synapses (Scr, black 
trace). Lower. Analysis of mEPSCs, from left to right, shown are mean ± SEM frequency, amplitude, area of mEPSCs calculated for PRRT2 KD 
(n = 11, red bars) and control (n = 15, black bars) neurons. All values were obtained from 100–1000 events recorded from each cell in 5-min 





For the analysis of evoked transmission, transduced autaptic neurons, identified 
as excitatory or inhibitory based on the kinetics of postsynaptic currents (PSCs) 
and sensitivity to specific blockers of AMPA or gamma-aminobutyric acid 
receptor type A (GABAA) receptors, were stimulated with paired stimuli at an 
interpulse interval of 50 ms to evaluate the paired-pulse ratio (PPR), an indirect 
measure of release probability (Fioravante and Regehr, 2011).  
In Valente et al. (2016), my research group has shows a dramatic decrease of 
eEPSC amplitude (Figure 9) in response to single stimuli with a strong increase in 
paired-pulse facilitation; this effect was reversible with co-infection of the 
neurons with Sh-resistant PRRT2 that was able to achieve a virtually complete 
return of current amplitude and PPR to the levels of Scr-infected neurons. A 
closely similar phenotype was observed in PRRT2-silenced inhibitory neurons, 
which represent 7%–10% of the total autaptic neuronal population under our 
culture conditions 
The PRRT2 deletion in treated neurons, suggest a presynaptic defect affecting 
release probability, thereby rendering facilitation more intense in excitatory 
synapses or depression milder in inhibitory synapses. 
 
 
Figure 9. On the left a representative eEPSCs recorded in excitatory autaptic neurons infected with Scr (black trace/ bar, n = 39), PRRT2-Sh4 
(red trace/bar, n = 32). eEPSCs were elicited by clamping the cell under study at –70 mV and stimulating it with two voltage steps to +40 
mV lasting 0.5 ms at an interstimulus interval of 50 ms. The paired-pulse stimulation was applied every 10 s (inset).  On the right decrease 




In Valente et al. (2016) my colleagues, also performed a cumulative evoked EPSC 
(eEPSC) amplitude analysis to identify the quantal parameters of release affected 
by PRRT2 silencing (Figure 10). Stimulating neurons  with a train of 2 s at 40 Hz, 
they shows a significant depression of eEPSCs became apparent during the train 
in both control and silenced neurons, irrespective of the amplitude of the first 
current in the train by a slower linear increase, reflecting the equilibrium 
between the depletion and constant replenishment of the RRP. The reduction of 
the current amplitude in silenced neurons was contributed by a sharp decrease 
in the initial Pr together with a significant decrease of the RRPsyn total current, 
in parallel of an unvaried number of readily releasable SVs (Nsyn) suggesting, a 
normal priming process generating the RRP in PRRT2 KD neurons. The substantial 
preservation of the total pool of readily releasable SVs indicates that the same 
total SV pool is shared by synchronous and asynchronous release and further 
suggests that SV priming is not affected by PRRT2 silencing. Therefore, the strong 
impairment in evoked synchronous release is likely to involve changes in the Ca2+ 






Figura 10. Upper. Representative recordings of eEPSCs evoked by high-frequency stimulation (train of 80 stimuli at 40 Hz, inset) in autaptic 
hippocampal neurons infected with Scr (black trace) or PRRT2-Sh4 (red trace). Stimulation artifacts were blanked for clarity. Profiles of the 
mean cumulative amplitude of eEPSCs. Data points in the 1- to 2-s range were fitted by a linear regression and back-extrapolated to time 0 
(solid lines) to estimate the RRPsyn. Lower.  Results of the quantal analysis. From left to right, shown are the mean ± SEM amplitude of the 
first eEPSC, RRPsyn size, number of RRPsyn quanta, and initial probability of release (Pr) estimated in neurons infected with Scr (n = 38, 
black bars) or PRRT2-Sh4 (n = 34, red bars). (Valente et al., 2016) 
Given the sharp impairment in spontaneous and evoked release, they 
investigated the Ca2+ sensitivity of release by increasing the extracellular Ca2+ 
concentration. In Scr-treated neurons, the increase in external Ca2+ from 2 to 4 
mM enhanced the amplitude of eEPSCs while decreasing PPR (Figure 11), 
consistent with a heightened release probability. Strikingly, PRRT2-silenced 
neurons were totally insensitive to the increase in extracellular Ca2+ as far as 
evoked release were concerned. 
 
Figura 11. eEPSC amplitude evoked by the first pulse (I1, left) and PPR (I2/I1, right) recorded in neurons transduced with Scr (black/gray 
bars, n = 7) or PRRT2- Sh4 (red/orange bars, n = 6). The graph bars represent the mean of the EPSC amplitude and PPR recorded in 
individual cells before (black/red bars) and after (gray/orange bars) the increase of the extracellular Ca2+ concentration to 4 mM. (Valente 
et al., 2016) 
Taken together, the data point to a fundamental role of PRRT2 in the machinery 
for synchronous release, whose strong decrease may depend on an impairment 
of Ca2+ secretion coupling or  Ca2+ entry. 
Thus, the investigation was focused on presynaptic proteins that, when deleted 
in knockout (KO) mice, cause a strong impairment in evoked release, including 
the SNARE proteins VAMP2, SNAP-25, syntaxin 1 and the fast Ca2+ sensors 
synaptotagmins (Syt) 1/2. Co-immunoprecipitation experiments from brain 
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extracts with anti-Syt1 and anti-Syt2 antibodies confirm showed that PRRT2 
indeed associates with both Syt1 and Syt2 (Figure 12 upper panels).  Both Syts 
isoforms were decreased in PRRT2 KD neurons. To evaluate whether the 
phenotype of PRRT2 KD is attributable to the interaction with either or both 
Syt1/Syt2, Valente and colleagues tried to rescue the impairment in the evoked 
synchronous release by overexpressing Syt2 in PRRT2 KD autaptic neurons 
(Figure 12 lower panels). Expression of Syt2 induced a significant but not 
complete rescue of PRRT2 KD-induced impairment in eEPSC amplitude, although 
its magnitude was smaller than the complete rescue obtained with Sh-resistant 
PRRT2. 
The lack of a full rescue obtained upon the reintroduction with Syt2 and the 
insensitivity to the increase in the external calcium (previously shown in Figure 
11), suggested us that acute knockdown of PRRT2 could not only play a role in 
the “Calcium sensing” but also in the “Calcium entry”. 
In other words, we speculated that the deletion of PRRT2 could negatively  affect 
presynaptic Ca2+ influx through presynaptic Ca2+ channels and from such 




Figura 12. Upper. Co-immunoprecipitation of PRRT2 with Syt1 and Syt2. Detergent extracts of mouse brain were immunoprecipitated (IP) 
with monoclonal antibodies (mAbs) specific for Syt1 and Syt2 or with the respective control mouse immunoglobulin Gs (IgGs) as indicated. 
After electrophoretic separation of the immunocomplexes and western blotting, membranes were probed with anti-Syt1/anti-Syt2 
antibodies to test the efficiency of the immunoprecipitation as well as with polyclonal anti-PRRT2 antibodies. Left: a representative 
immunoblot is shown. Right: quantification of the PRRT2 immunoreactive signal in the immunoprecipitated samples, normalized to the 
binding to the mouse IgG control (means ± SEM, n = 3 independent experiments). Input, 10 mg total extract. Lower. Overexpression of Syt2 
partially rescues the impairment in synchronous release of PRRT2 KD neurons. Autaptic hippocampal neurons were infected at 7 DIVs with 
Scr (n = 31), Sh4/mCherry (Sh4, n = 30), Syt2/GFP (Syt2, n = 28), or Sh4+Syt2 (n = 27) and recorded at 14 DIVs. The histograms show the 
means ± SEM of the eEPSC amplitude evoked by the first pulse (I1, left) and of the PPR (I2/I1, right). *p < 0.05, **p < 0.01; ***p < 0.001; 
Kruskal Wallis/Dunn’s multiple comparison test (I1); one-way ANOVA/Bonferroni’s multiple comparison test (PPR). (Valente et al., 2016) 
4. Calcium Channels 
 
Calcium influx into presynaptic nerve terminals via voltage-gated Ca2+ channels is 
an essential step in neurotransmitter release. Voltage-gated Ca2+ channels are 
key routes for Ca2+ entry into electrically excitable cells. Increases in free 
intracellular Ca2+ concentrations are linked to a plethora of cellular responses, 
including the activation of Ca2+ dependent enzymes, initiation of gene 
transcription, and the release of neurotransmitters from presynaptic sites (Reid, 
C.A. et al. 2003). Multiple types of voltage-gated Ca2+ channels are expressed 
throughout the nervous system and these differ in their cellular and subcellular 
distributions, biophysical and pharmacological properties, and physiological roles 
(Snutch, T.P. et al. 2005).  
Early electrophysiological recordings from neurons suggested the existence of 
two major classes of Ca2+ channels based upon the membrane potentials at 
which they first open: low-voltage activated (LVA) and high-voltage activated 
(HVA). The LVA (or T-type) channels, typically have a small conductance (8-12 
pico Siemens (pS)), open in response to small changes from the resting 
membrane potential and inactivate rapidly kinetics (Carbone et al., 2014). In 
contrast, the HVA (L-, N-, P/Q- and R-type) currents generally possess larger 
conductances (15-25 pS), are activated by stronger depolarizations and display 
variable inactivation kinetics. Nine individual neuronal voltage-gated Ca2+ 
channels have been identified and classified by their biophysical and 
pharmacological profiles as L-, N-, P-, Q-, R- or T-types. This diversity arises 
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predominantly from the nature of the principal pore-forming a1 subunit. There 
are three different families of Ca2+ channel a1 subunits: Cav1 genes encode L-
type channels, Cav3 genes encode T-type channels, and Cav2 genes encode N-
type, P/Q-type and R-type channels, with P-type and Q-type channels arising 
from alternative splicing of the Cav2.1 gene (Catterall, W.A. 2000). The a1 subunit  
comprises four homologous transmembrane domains (I–IV), each of which 
contains six membrane spanning helices (S1–S6) plus a reentrant p-loop motif 
that lines the channel pore to enable passage of Ca2+. The four domains are 
connected through cytoplasmic linkers, and both C and N termini are cytoplasmic 
(Figure 13). These regions form key interaction sites for regulatory proteins. 
Members of the Cav1 and Cav2 families associate with ancillary b subunits 
(encoded by four different genes), a2–d subunits (four different genes) and 
possibly g subunits (eight different genes), which aid membrane expression and 
alter the biophysical characteristics of the a1 subunit (Arikkath, J. and Campbell, 
K.P. 2003; Klugbauer, N. et al. 2003; Kang, M.G. and Campbell, K.P. 2003). The b 
subunit is a cytoplasmic protein that binds to the a1 subunit domain I–II linker 
(Van Petegem, F. et al. 2004). The a2–d subunit is translated as a single protein 
but cleaved into d (a single transmembrane-spanning helix) and a2 (the 
extracellular domain), which are linked by a disulfide bonds; however, its 
interaction site on the Ca2+ channel a1 subunit is unknown.  
L-type Ca2+ channels were initially described in peripheral neurons and cardiac 
cells, but appear to be present in all excitable as well as many types of non-
excitable cells. In certain cells, L-type channels have been shown to be 
preferentially localized to specific subcellular regions. The L-type channel is the 
primary route for Ca2+ entry into cardiac, skeletal, and smooth muscles. The 
skeletal muscle L-type channel acts as a voltage sensor for excitation-contraction 
(E-C) coupling in skeletal muscle, presumably linking membrane depolarization to 
Ca2+ release from intracellular stores. While Ca2+ entry through this channel is 
not required for the initiation of contraction in skeletal muscle, it may provide a 
source of Ca2+ to replenish internal stores.  
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The predominant Ca2+ channel subtypes in synaptic nerve terminals are P/Q-type 
and N-type channels, where their opening is linked to the rapid release of 
synaptic vesicles (Reid, C.A. et al. 2003). Although both N-type and P/Q-type 
channels primarily support neurotransmitter release at hippocampal synapses 
(Wu, L.G. and Saggau, P. 1994; Scholz, K.P. and Miller, R.J. 1995; Reid, C.A. et al. 
1997; Reid, C.A. et al. 1998; Wheeler, D.B. et al. 1996; Qian, J. and Noebels, J.L. 
2001), cerebrocortical synapses (Millan, C. et al., 2002; Mintz, I.M. et al. 1995) 
and calyx-type synapses (Wu, L.G. et al. 1999). R-type channels make a small 
contribution to evoked transmitter release in some preparations (Iwasaki, S. and 
Takahashi, T. 1998; Gasparini, S.A. et al. 2001) but play a more important role in 
synaptic plasticity (Dietrich, D. et al. 2003). L-type and T-type Ca2+ channels are 
not normally involved in excitatory transmitter release.  
The a1 pore-forming subunit is a key determinant of the properties of Ca2+ 
channel subtypes (Catterall, W.A. 2000), with P/Q-type channels containing a1A 
subunits (Cav2.1), N-type channels containing a1B subunits (Cav2.2) and R-type 
channels containing a1E subunits (Cav2.3) (Ertel, E.A. et al. 2000). Mixed 
population of N-type and P/Q-type Ca2+ channels can coexist at a single release 
site and contribute jointly to the local Ca2+ transient that triggers transmitter 
release. This view is supported by several findings. Both N-type and P/Q-types of 
Ca2+ channel support the release of glutamate at excitatory synapses in the 
hippocampus (Luebke et al., 1993; Wu and Saggau, 1994b; Scholz and Miller, 
1995) and in the cerebellum (Mintz et al., 1995; Regehr and Mintz, 1994). Several 
lines of evidence suggest that a mixed population of Ca2+ channel subtypes 
coexists at individual synaptic terminals and cooperate to support 
neurotransmitter release (Takahashi and Momiyama, 1993; Castillo et al., 1994; 
Regehr and Mintz, 1994; Wheeler et al., 1994a, 1996; Wu and Saggau, 1994b; 
Mintz et al., 1995). The mix of subtypes may not be the same at all terminals, and 
it has been suggested that N-type Ca2+ channels are solely responsible for 
neurotransmitter release at a subset of terminals (Reuter 1995; Wheeler et al. 
1996). Both N-type and P/Q-types of Ca2+ channels can be modulated 
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differentially (Wu and Saggau, 1994b; Wu and Saggau, 1995). Thus, a non 
uniform distribution of Ca2+ channel subtypes could permit selective alteration of 
transmitter release at groups of terminals on a single afferent, which would have 
important ramifications for synaptic modulation and plasticity.  
A mixed population of N-type and P/Q-type Ca2+ channels can coexist at a single 
release site and contribute jointly to the local Ca2+ transient that triggers 
transmitter release. This view is supported by several findings. The most 
convincing is that the percentage block of synaptic current by a selective N-type 
antagonist and the block by a selective P/Q-type antagonist sum to +/-100% 
(Reid, C.A. et al. 1997; Wu, L.G. and Saggau, P. 1994; Wheeler DB et al., 1996). 
Supra-additivity can be explained only if Ca2+ entering through N-type channels 
can reach the same vesicle release site as Ca2+ entering through P/Q-type 
channels, on the timescale of transmitter release. This evidence (Reid, C.A. et al. 
2003) supports a colocalization of both channel subtypes at some presynaptic 
terminals, but it does not demonstrate that all terminals contain both subtypes. 
Both N-type and P/Q-type Ca2+ channels contain a specific synaptic protein-
interaction site (‘synprint’) in the intracellular loop that links domains II and III 
(Rhian M. et al. 2006); this site binds synaptic proteins such as syntaxin 1, 
synaptosome-associated protein of 25 kDa (SNAP-25), cysteine string protein 
(CSP), Rim and synaptotagmin 1 (Figure 13). 
Besides being a key synaptic targeting motif (Mochida,S. et al. 2003; Szabo, Z. et 
al. 2006), the synprint region seems to be an important modulatory site that 
enables synaptic proteins to regulate channel activity per se. In both transient 
expression systems and neurons, binding of syntaxin 1 and SNAP-25 results in a 
hyperpolarizing shift in the potential at which half of the P/Q-type and N-type 
Ca2+ channels in a sample are inactivated (the half-inactivation potential), thus 
reducing channel availability (Verderio, C. et al. 2004; Bergsman, J.B. and Tsien, 
R.W. 2000; Stanley, E.F. 2003) and presumably the amount of neurotransmitter 
that is released. N-type and P/Q-type channels undergo different inhibition in 
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response to activation of G-protein-coupled receptors (GPCRs; Carbone, Carabelli 
et al., 2001; Zamponi, G.W. 2001; Strock, J. and Diverse-Pierluissi, M.A. 2004). 
Although both N-type and P/Q-type Ca2+ channels are regulated by second 
messenger activity and associate with synaptic vesicle release machinery, they 
differ in their precise regulation and in their abilities to integrate multiple 
signaling inputs. 
 
Figura 13. Structural aspects of voltage-gated Ca2+ channels. Subunit composition of Ca2 +channels and putative transmembrane topology of 
the α1 subunit. Key protein interaction sites are indicated. Red circles represent key phosphorylation sites and plus symbols denote the 
voltage-sensitive membrane-spanning helix of each domain. G-protein βγ subunits might interact at a macrosite formed by binding of the N 
terminus to the domain I–II loop.  (Rhian M. et al. 2006) 
Pharmacological studies that  involve  selective  calcium  channel  antagonists 
(Wheeler DB et al. 1994), and   immunocytochemical   characterization   of   
calcium channel distribution (Westenbroek RE et al 1992; Westenbroek RE et al. 
1998; Timmermann DB et al. 2002), suggest that the N-type and P/Q-type 
calcium channels are the predominant species involved  in  synaptic  
transmission.  Because  of  the  high buffering  capacity  of  neurons,  it  is  
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thought  that  free calcium  ions  diffuse  only  short  distances  before  being 
sequestered by calcium binding proteins, which results in a  steep  drop  in  
intracellular  calcium  concentration  that radiates from the inner mouth of the 
calcium channel pore in to the cytoplasm (Augustine GJ 2001). Additionally, the 
putative calcium sensor(s), such as synaptotagmin, are considered to have a 
relatively  low  affinity  for  calcium (Augustine GJ 2001).  Hence,  to  sense 
calcium  entry,  the  vesicular  release  machinery  must  be localized in close 
proximity to presynaptic calcium channels. Indeed, the presynaptic calcium 
channels of vertebrate   neurons   display   a   highly   restricted   subcellular 
distribution in the active zone, and co-localize with the vesicular release 
machinery (Westenbroek RE et al. 1998). This gives rise to what are 
expected/observed   to   be   highly   ordered   presynaptic ultrastructures that 
can, as in the case of the frog neuro-muscular  junction,  result  in  the  formation  
of  a  protein scaffold  that  supports  rows  of  docked  synaptic  vesicles 
connected to the plasma membrane (Harlow ML et al. 2001). Biochemical 
evidence has demonstrated that key synaptic proteins involved in the docking of 
synaptic vesicles to the active zones — syntaxin1, SNAP25 and synaptotagmin  1  
—  bind  to  a 225  amino  acid  stretch  in  the intracellular domain II-III linker 
region of thea1subunitof  mammalian  N-type  and  P/Q-type  calcium  channels 
(termed  synaptic  protein  interaction  or  ‘synprint’  site)(Bennett et al., 1992; 
Leveque C et al., 1994; Sheng Z et al., 1994, 1996, 1997; Rettig Jet al., 1996). This 
site is considered unique to vertebrate Cav2.2 (N-type) and Cav2.1 (P/Q-type) 
channels, as corresponding regions of other calcium channel subtypes such  as  L-
type (Sheng Z et al., 1994; Rettig Jet al., 1996) or  R-type (Pereverzev A et al., 
2002) do  not  appear  to associate with syntaxin1 or SNAP25in vitro. The  
presence  of either   syntaxin1A,   syntaxin1B   or   SNAP25   results   in decreased 
channel availability because of a hyperpolarizing  shift  in  the  voltage-
dependence  of  inactivation  of transiently  expressed (Bezprozvanny I et al., 
1995; Bezprozvanny I et al., 2000; Zhong H et al., 1999; Jarvis SE  et al., 200; 
Jarvis SE  et al., 2001) and  native  N-type and  P/Q-type  calcium  channels  
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(Bergsman JB et al., 2000). Interestingly, in the presence of   both   syntaxin1   
and   SNAP25,   channel   availability becomes  normalized,  which  would  favor  
calcium  entry through  channels  that  are  capable  of  docking  to  a  pre-





















5. Aims of the project 
 
The goal of my research project was the investigation of the altered Ca2+ 
dependence of the synaptic transmission as a possible causative role in the 
pathogenesis of PRRT2-Diseases 
I focused my research activity on the study of presynaptic calcium influx involved 
in the impairment of the synaptic transmission  caused by acute and chronic 
deletion of PRRT2. 
I have used various technical approaches: electrophysiology, 
immuncitochemistry, biochemistry and live calcium imaging aimed to analyze 
changes of somatic and presynaptic voltage gated calcium channel subtypes in 
PRRT2-deficient neurons. 
In particular I have studied: 
• The effects of PRRT2 deletion on the glutamate neurotransmission in 
relation to the increase of extracellular calcium concentration. 
• The effects of PRRT2 acute/chronic deletion on the different presynaptic 
VG-Ca2+ channel subtypes that contribute to glutamatergic synaptic 
transmission. 
• The effects of PRRT2 acute/chronic deletion or PRRT2 over-expression on 
the somatic L-type, N-type and P/Q-type VG-Ca2+ currents.  
• The effect of PRRT2 chronic deletion on the intracellular and membrane 
expression of P/Q- and N-type VG-Ca2+ channels.  
• The effect of PRRT2 deletion on the localization of P/Q-type VG-Ca2+ 
channels at presynaptic boutons. 
• The effect of PRRT2 acute deletion or over-expression on the presynaptic 
calcium signal dependent on P/Q-type VG-Ca2+ channels. 
I based my investigation on three different experimental in vitro models: 
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1) WT cultured hippocampal neurons infected at 6 div with a lentiviral 
vector transducing a shRNA inducing an efficient knockdown of PRRT2 
expression (Valente et al., 2016) at 6 days after the infection (12 div). 
2) WT cultured hippocampal neurons infected at 6 div with a lentiviral 
vector transducing the native form of PRRT2, able of inducing over-
expression of the protein at 12 div (Valente et al., 2016) 
3) Cultured hippocampal neurons obtained from PRRT2 knockout (KO) mice, 
developed by EUCOMM/KOMP that we have extensively previously 




















6.1 PRRT2 knockdown and knockout reduced the enhancement of 
eEPSCs induced by increasing extracellular Ca2+ concentration 
 
We recorded evoked excitatory synaptic transmission in hippocampal autaptic 
neurons infected with a Lentiviral Vector encoding a short hairpin RNAs (shRNAs) 
named SH4, able to massively reduce the expression of the endogenous PRRT2 
protein, or with the Scramble (named scrRNAs) control RNA (previously validated 
in Valente et al., 2016). 
The over-expression of PRRT2 was obtained using a lentiviral vector that 
expresses the native form of the PRRT2 protein (named OVER) or mCherry 
control RNA. Neurons were infected at 6 DIV and electrophysiological 
experiments were conducted between 11 and 14 DIVs (figure 14).  
Electrophysiological recordings were performed at increasing extracellular Ca2+ 
concentration. We prepared 4 external solutions with a calcium concentration 
of: 0.5, 1, 2, 4 mM. In these 4 solutions, the concentration of magnesium was 
progressively decreased from 3.5 to 0 mM, with the goal of maintaining constant 
the total concentration of bivalent cations ([Mg2+] + [Ca2+]= 4 mM). We also used 
a concentration of 8 mM Ca2+ (0 Mg2+) to better appreciate saturation of the 
dose-response curve. 
Voltage-clamp (VC) recordings of eEPSCs were performed using a VC stimulation 
protocol aimed to maintain the patched-neuron to a holding potential (Vh) of -70 
mV. The excitatory glutamatergic transmission was evoked thank to a brief (0.5 






Figure 14. Representative experimental procedure for eEPSC recording. Graphic explanation (upper) of infection of autaptic hippocampal 
neurons at 6 DIV and recording with a crescent concentration of extracellular calcium and its consequent (lower) increase of synaptic 
current. 
The dose-response curves showing the mean of eEPSCs amplitude at various 
[Ca2+]o were fitted using a sigmoidal Hill Equation:  
eEPSCs (pA)= IMax*[Ca2+]on/ ([Ca2+]on +EC50) where:  
• IMax represents the saturation level of the curve;  
• n, named Hill coefficient, represents the slope of the dose-response curve 
at a [Ca2+]o=EC50;  
• EC50 represents the [Ca2+]o at which it was observed an eEPSC amplitude 
= IMax/2. 
Both acute and chronic deletion of PRRT2 did not significantly affect the Hill 
Coefficient (Figure 15), that show a mean value of ~3.5, in accord with the strong 
positive cooperativity that has been previously shown for the Calcium 
dependency of the glutamatergic synaptic transmission (Valente et al., 2016). 
37 
 
Also, the affinity constant (EC50) was not affected by acute and chronic deletion 
of PRRT2 (Figure 15). On the contrary the lack of PRRT2 induced a strong 
reduction of the largest eEPSCs evoked at higher calcium concentration. Such 
effect was particularly evident in knock-down neurons while it was strongly 
attenuated in knock-out cells (Figure 15). 
 
Figure 15. Dose-response curves of the amplitude of the eEPSCs at increasing extracellular calcium concentration. (A) the graph show the 
mean eEPSCs induced at various extracellular calcium concentration in scr (n=37)/SH4 (n=36) infected neurons *p<0.05 t student (B) the 
graph show the mean eEPSCs induced at various extracellular calcium concentration in WT (n=53)/KO (n=52) infected neurons *p<0.05 t 
student  
 
We also studied paired-pulse facilitation induced by the administration of two 
consecutive voltage stimuli at a time interval of 50 ms (Figure 16). We observed a 
decreased of synaptic facilitation at higher extracellular calcium concentration 
(4-8 mM). Notably, the calcium dependent reduction of the facilitation was 
significantly decreased by PRRT2 deletion (Figure 16). 
These results suggest that PRRT2 deletion could reduce presynaptic calcium 
influx through a negative modulation of VG-calcium channels. To test this 
hypothesis, we evaluated the contribution of individual VG-calcium channels 





Figure 16. PRRT2 deletion decreased the reduction of synaptic facilitation at higher external calcium concentration. eEPSCs were elicited by 
clamping the cell under study at –70 mV and stimulating it with two voltage steps to +40 mV lasting 0.5 ms at an interstimulus interval of 
50 ms. The paired-pulse stimulation was applied every 10 s. (A)  Mean ± S.E.M. of the PPR at increasing calcium concentration in scr 
(n=37)/SH4 (n=36) and (B)  WT (n=53)/KO (n=52) infected neurons *p<0.05 t student  
 
6.2 PRRT2 acute/chronic deletion affects the contribution of 
presynaptic VG-Ca2+ channels to glutamatergic synaptic 
transmission 
 
To evaluate the contribution of the voltage-gated calcium channels to the 
glutamatergic synaptic transmission, we initially recorded eEPSCs from autaptic 
neurons lacking PRRT2. eEPSCs recordings were conducted between 11 and 14 
DIV at standard extracellular calcium concentrations (2 mM) and in the presence 
of 3 different VG-calcium channels selective antagonists. Nifedipine (5 µM ) was 
used to block the eEPSCs due calcium influx through L-Type calcium channels, 
Agatoxin-IVA (0.2 µM) was used to block the eEPSCs dependent on activation of 
P/Q-Type calcium channels and Conotoxin-GVIA (3 µM) was used to block the 




Figure 17. Graphical representation of the effect of toxins overtime on the synaptic current. eEPSCs were elicited by clamping the cell 
under study at –70 mV and stimulating it with a voltage steps to +40 mV lasting 0.5 ms. The stimulation was applied every 10 s. Toxins were 




Calcium channels antagonists were applied into the recording solution after the 
stabilization of the eEPSC amplitde  (≈ 2/3 minutes) and maintained until the 
next stabilization of the eEPSC amplitude in presence of the antagonists (Figure 
17). 
Nifedipine was used to block L-type voltage-gated calcium channels. As 
expected, (Pfrieger et al., 1992) the block of the L-type channels does not reduce 
the synaptic current in the control neurons and in PRRT2 KD/KO neurons (Figure 
18). 
Thus, we studied P/Q-type channels contribution to excitatory synaptic 
transmission. The percentage block of Agatoxin-IVA (≈40%) on the eEPSCs 
amplitude was not affected by acute/chronic deletion of PRRT2 while it was 
significantly reduced the amount of Aga-IVA sensitive eEPSCs, calculated as the 
difference between the control eEPSCs and the current that remains after the 
blockage of the P/Q-type channels (Figure 19). 
Similar results were obtained in presence of Conotoxin-GVIA, a selective N-type 
channels blocker. Indeed, the percentage block of Cono-GVIA (≈30%) was not 
affected by acute/chronic deletion of PRRT2 while it was significantly reduced 
the amount of Cono-GVIA sensitive eEPSCs (Figure 20).  
These results demonstrated that the lack of PRRT2 selectively reduced the 
glutamate release dependent on N- and P/Q-type calcium channel subtypes, 
suggesting that presynaptic N- and P/Q-type channels expression or function 
could be altered by PRRT2 deletion.  At the light of these data, the next step was 







Figure 18. L-Type channels did not contribute to excitatory synaptic transmission in both control and PRRT2 lacking neurons. (A) Bar plots 
show mean ± S.E.M. eEPSCs in control condition and in presence of Nifedipine (5µM). (B) The graph shows the mean ± S.E.M % block 
eEPSCs induced by Nifedipine in scr (red, n=6) and SH4 (blu, N=7) p>0.05 unpaired t student (C) The graph shows the mean ± S.E.M of Nife-
sensitive EPSC in scr (red, n=6) and SH4 (blu, N=7) p>0.05 unpaired t student. (D) Bar plots show mean ± S.E.M. eEPSCs in control condition 
and in presence of Nifedipine (5µM). (E) The graph shows the mean ± S.E.M % block eEPSCs induced by Nifedipine in WT (red, n=8) and KO 
(blu, N=7) p>0.05 unpaired t student (F) The graph shows the mean ± S.E.M of Nife-sensitive EPSC in WT (red, n=8) and KO (blu, N=7) 




Figure 19. P/Q-Type channels contribution to excitatory synaptic transmission in both control and PRRT2 lacking neurons. (A) Bar plots 
show mean ± S.E.M. eEPSCs in control condition and in presence of Agatoxin (0,2µM). (B) The graph shows the mean ± S.E.M % block 
eEPSCs induced by Agatoxin in scr (red, n=15) and SH4 (blu, N=10) p>0.05 unpaired t student (C) The graph shows the mean ± S.E.M of Aga-
sensitive EPSC in scr (red, n=15) and SH4 (blu, N=10) p>0.05 unpaired t student. (D) Bar plots show mean ± S.E.M. eEPSCs in control 
condition and in presence of Agatoxin (0,2µM). (E) The graph shows the mean ± S.E.M % block eEPSCs induced by Agatoxin in WT (red, 
n=14) and KO (blu, N=15) p>0.05 unpaired t student (F) The graph shows the mean ± S.E.M of Aga-sensitive EPSC in WT (red, n=14) and KO 




Figure 20. N-Type channels contribution to excitatory synaptic transmission in both control and PRRT2 lacking neurons. (A) Bar plots show 
mean ± S.E.M. eEPSCs in control condition and in presence of Conotoxin (3µM). (B) The graph shows the mean ± S.E.M % block eEPSCs 
induced by Conotoxin in scr (red, n=11) and SH4 (blu, N=13) p>0.05 unpaired t student (C) The graph shows the mean ± S.E.M of Cono-
sensitive EPSC in scr (red, n=11) and SH4 (blu, N=13) p>0.05 unpaired t student. (D) Bar plots show mean ± S.E.M. eEPSCs in control 
condition and in presence of Conotoxin (0,2µM). (E) The graph shows the mean ± S.E.M % block eEPSCs induced by Conotoxin in WT (red, 
n=15) and KO (blu, N=14) p>0.05 unpaired t student (F) The graph shows the mean ± S.E.M of Cono-sensitive EPSC in WT (red, n=15) and 
KO (blu, N=14) p>0.05  unpaired t student. 
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6.3 Pharmacological dissection of somatic VG-Ca2+ currents 
 
Voltage-gated calcium currents were recorded in low density cultured 
hippocampal neurons maintained for 10/14 days in vitro (10-14DIV).  
The hippocampal neurons were obtained from postnatal (P0-P1) GAD67-GFP 
transgenic mice (Tamamaki N. et al., 2003).  
In these mice, the fluorescent protein reporter, GFP, was specifically expressed in 
GABAergic neurons, under the control of the endogenous GAD67 promoter. GFP 
substitutes the introns in the 5’ and 3’ flanking region in one of the two GAD67 
alleles. Thanks to this knock-in, we were able to clearly distinguish GAD67-GFP 
positive inhibitory interneurons from GAD67-GFP negative excitatory neurons 
(Figure 21B). 
Neurons were infected by the addition of lentiviral vectors into cell medium at 
10 DIVs. We have identified excitatory and infected neurons thanks to their 
negativity to GAD67-GFP and positivity to mCherry, respectively (Figure 21A). 
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Figure 21. (A) The picture show the infection procedure adopted in cultured hippocampal neurons obtained from GAD67-GFP transgenic 
mice. (B) Micro photographs representing GAD67-GFP positive and negative neurons infected with scramble or SH4 RNA. 
Low-density cultured hippocampal neurons express a cocktail of different LVA 
and HVA voltage-gated Ca2+ channels. In our cultured hippocampal neurons, we 
used patch-clamp recordings to investigate HVA calcium currents activated by 
100-msec voltage steps from -70 mV to +70 mV in 10-mV increments from a 
holding potential of -70 mV at 0.2 Hz. This stimulation protocol allowed us to 
characterize the I/V (current/voltage) relationship and to reveal that the 
maximum Ca2+ current was elicited by 100-msec voltage pulses to -10 mV from 
the holding potential of -70 mV (Figure 22).   
We used the above described test pulse to evaluate the effect of Nifedipine (5 
µM), a selective blocker of L-Type Ca2+ currents, Agatoxin-IVA (0,2 µM) a 
selective blocker of P/Q-Type Ca2+ currents and Conotoxin-GVIA (3 µM) a 
selective blocker of N-Type Ca2+ currents (Figure 22 red traces).  
Nifedipine is very useful because allowed to isolate non-L type Ca2+ currents from 
the somatic L-type currents. Note that  DHP-sensitive L-type Ca2+ channels are 
mainly expressed at the level of the cell body, while DHP-insensitive, non-L types 
Ca2+ channels, mainly represented by R-, N- and P/Q-types, play a role at both 
the cell body and the presynaptic terminal, where they mediate Ca2+ influx 
activating fast synaptic vesicles release. These results revealed that at -10mV 
about 40% of the total calcium currents was due to L-type Ca2+ channels while 
the remaining 60% of non-L type Ca2+ currents was due to R-, N- and P/Q-types 
channel activation.  
PRTT2 deletion did not affected membrane capacitance (Cm) in neurons 
overexpressign PRRT2 ( CmmCherry=58,31 pF: CmOVER= 55,45 pF) and in neurons 
were PRRT2 was acutely deleted ( Cmscr= 76,09 pF, CmSH4=71,85pF) or in neurons 
where PRRT2 was chronically deleted  (CmWT= 45,40 pF; CmKO= 45,85 pF). For this 
reason, we plotted absolute value of the calcium current intensity (ICa2+=pA), but 
we have also calculated Ca2+ current density (DCa2+=pA/pF) (data not shown) 
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obtaining similar results in term of changes due to PRRT2 over-expression or 
deletion. 
 
Figure 22. Representative scheme of the recording protocols used to isolate the calcium currents under control conditions (black trace) and 
in the presence of the three toxins (red trace) with a comparison of current intensity under control conditions (black trace) and post-toxins 
treatment (red trace).  
6.3.1 Isolation of L-Type Ca2+ currents in hippocampal neurons overexpressing 
or lacking PRRT2 
 
Hippocampal neurons have been infected with a shRNA, able to silence PRRT2 
expression at 10 DIV and then recorded at 15 DIV to evaluate calcium currents 
intensity. 
Patch-clamp recording revealed that total calcium currents are enhanced by 
PRRT2 over-expression while it was reduced by the acute deletion of PRRT2 
(Figure 23A). These effects were further enhanced in presence of nifedipine 
suggesting that the lack of PRRT2 mainly affects non-L-type calcium current 
(Figure 23B), the calcium channel subtypes that drive NTs release at the 
presynaptic terminals. In accord with these results we also observed that PRRT2 
deletion did not affect L-type calcium currents isolated subtracting Nife-
insensitive currents from the total calcium currents (Figure 23C). 






Figure 23. The graph show the current vs voltage relationships of total, non-L and L-type calcium current recorded in cherry(pink; 
n=8)/OVER(green; n=7) and scr(blu; n=8)/SH4(red; n=10) neurons. Statistical analysis was performed at -10 mV. *P < 0.05, **P < 0.01; 
Mann-Whitney U test. 
 
6.3.2 Isolation of P/Q- and N-Type Ca2+ current in hippocampal neurons 
overexpressing or lacking PRRT2   
Thanks to the experiments conducted in presence of Nifedipine, we identified 
the non-L-type channels as the main VGCCs subtypes sensitive to PRRT2 deletion. 
For this reason, we used the same protocol previously described (Figure 22), to 
evaluate the effect of PRRT2 deletion on the P/Q- and N-type calcium currents. 
P/Q-type calcium currents (Figure 24C) have been isolated subtracting Aga-IVA-
insensitive calcium currents (Figure 24B) from the total calcium currents (Figure 
24A) that have been recorded in presence of Aga-IVA and in control condition, 
respectively. This analysis revealed that PRRT2 over-expression increased P/Q-





Figure 24. The graph show the current vs voltage relationships of total, non-P/Q and P/Q-type calcium current recorded in cherry(pink; 
n=9)/OVER(green; n=7) and scr(blu; n=9)/SH4(red; n=10) neurons. Statistical analysis was performed at -10 mV. *P < 0.05, **P < 0.01; 
Mann-Whitney U test. 
 
We observed a similar behavior, isolating N-type currents, thanks to the 
application of the Conotoxin-GVIA.  Indeed, PRRT2 overexpression and silencing 
increased and decreased the total Ca2+ currents, respectively (Figure 25A). Such 
effect was lost on non N-type currents (Figure 25B), and in accord with these 
result the isolation of pure N-type Ca2+ currents, obtained subtracting Cono-
insensitive current from the total current, were strongly affected by the change 







Figure 25. The graph show the current vs voltage relationships of total, non-N and N-type calcium current recorded in cherry(pink; 
n=10)/OVER(green; n=8) and scr(blu; n=10)/SH4(red; n=12) neurons. Statistical analysis was performed at -10 mV. *P < 0.05, **P < 0.01; 
Mann-Whitney U test. 
 
To confirm these results, obtained with the acute PRRT2 deletion, we repeated 
the same experimental procedure comparing WT and PRRT2 KO neurons. The 
graphs shown in Figure 26, basically demonstrates that the chronic deletion of 
PRRT2 exerted the same effect observed in presence of the acute deletion (KD) 
of PRRT2 (Figure 23,24 and 25) with a significant reduction of both N- and P/Q-








Figure 26. The graph show the current vs voltage relationships of total, non-L-, P/Q-, N and L-, P/Q-, N-type calcium current recorded in 
WT(red; n≈11)/KO(blu; n≈11) neurons. Statistical analysis was performed at -10 mV. *P < 0.05, **P < 0.01; Mann-Whitney U test. 
These results suggested that PRRT2 could play a role in the expression level of N- 














6.4 VG-Ca2+ channels expression and membrane trafficking in PRRT2 
KO neurons 
Thus, we investigated whether the absence of PRRT2 affected P/Q-type VGCCs 
expression or their trafficking to the membrane by surface biotinylation of 
neurons.  
Biotinylation of intact cells has emerged as an important tool for studying the 
expression and regulation of channels, receptors and transporters and others 
membrane proteins from the cytoplasmatic organelles to the plasma-membrane 
(as previously described in Fruscione et al., 2018). 
Our data indicate that PRRT2 KO neurons show a significant decrease of the 
extracellular levels of P/Q-type VGCCs compared with WT neurons, with a 
parallel significant increase in the intracellular fraction (Figure 27). These results 
suggest that the lack of PRRT2 impaired the correct targeting of P/Q-type VGCCs 
to the plasma-membrane, generating an intracellular accumulation of the P/Q-
type channels.  
This data also suggests that PRRT2 thanks to a possible direct or indirect 
interaction with the presynaptic P/Q-type VGCCs channels could play a role in 
their correct synaptic localization, keeping most of the P/Q-channels 
intracellularly and therefore impairing their correct contribution to the process 
of neurotransmitter release. 
 
Figure 27. On the left representative immunoblots of cell surface biotinylation performed in primary cortical WT or PRRT2 KO neurons. 
Total cell lysates (input), biotinylated (cell surface, extracellular) and non-biotinylated (intracellular, intracellular) fractions were analyzed 
by immunoblotting. Na/K-ATPase and actin were included as markers of the plasma membrane and cytosolic fractions, respectively. On the 
right the extracellular and intracellular P/Q-type VGCCs expression was normalized on Na/K-ATPase and actin expression (n=5 independent 
preparations). Data are shown as means ±sem. *p<0.05 Student’s t-test. 
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6.5 PRRT2 alters the localization of P/Q-type VG-Ca2+ channels at 
presynaptic boutons 
 
With the aim of investigating in more detail such interesting biotinylation results, 
we analyzed synaptic localization of P/Q-type calcium channels, by an 
immunocytochemical approach combined with confocal imaging analysis. 
Cultured WT and PRRT2 KO hippocampal neurons were maintained in vitro for 14 
days and then fixed, permeabilizated and double-stained for Cav2.1, the alfa1 
subunit of the P/Q-type VGCCs, and bassoon, a presynaptic protein crucial for 
the correct function of the release-machinery molecular complex (Figure28A; 
Thalhammer et al., 2017). We used the colocalization of bassoon and Cav2.1  for 
identifying putative synaptic contacts and for investigating a possible mis-





Figure 28. PRRT2 deletion impaired the correct localization of P/Q type VGCCs to the presynaptic boutons. (A) Double-immunostaining for 
Bassoon (red) and Cav2.1 (green) was used for investigating the localization of P/Q-type calcium channels at the presynaptic boutons in WT 
(left) and KO neurons (right). (B) Bottom panels show the distribution profile of the immuno-fluorescence intensity for Cav2.1 (green) and 
bassoon (red) for two (WT-left and KO-right) representative synaptic boutons. 
We observed that the chronic deletion of PRRT2 moderately decreases the 
synaptic density (Figure 29A), in accordance with previous results of our research 
group (Valente et al. 2019). 
By measuring the area of the Cav2.1 positive puncta, co-localizing with the 
bassoon positive puncta, we observed an increase in the size of the boutons 
(Figure 29B) and in agreement with this result we also observed an increase of 
the Manders’ coefficient (Figure 29C). 
Moreover, the chronic deletion of PRRT2 reduces the Cav2.1 integrated 





Figure 29. The Lack of PRRT2 moderately decreases the synaptic density and increased the dispersion of Cav2.1 out-side the active zone.  
(A) The bar graph shows that chronic deletion of PRRT2 moderately decreases the synaptic density; Panel (B) shows a significant increase of 
the bouton size (estimated measuring the area of the Cav2.1 positive puncta co-localizing with the Bsn positive puncta). In accord with this 
result panel (C) shows an increase of the Manders’ coefficient. Panel (D) shows that the chronic deletion of PRRT2 decreases the integrated 
intensity of Cav2.1/bsn positive puncta  (WT n=32/KO n=33, P<0.05; **, P<0.01 e U test pert tutti I pannelli). 
These effects strongly suggest that the lack of PRRT2 induced a mis-localization 
of P/Q-type channels that diffuse outside the active zone (Figure 30). 
In other words, these results suggest that in KO neurons, P/Q-type calcium 
channels mis-targeted the  presynaptic membrane (the active zone) because of 
an impairment in the trafficking from the intracellular organelle membranes to 
the plasma membrane (see byotinilation results) and/or an enhanced  diffusion 
and consequent dis-localization of P/Q-type  channels outside and far-away the 
active zone (Figure 30).  
For this reason, the area of colocalization between bassoon and Cav2.1 increased 
and consequently a similar increase was also observed in the coefficient of 
Manders’ coefficient (P<0.05, P=0.0004) and in the bouton size (P<0.05, 
P=0.0376), leading to the reduction of the Cav2.1 integrated fluorescence  
intensity (P<0.05, P=0.0011),  due to the difficulty of the P/Q channels to stay 
clustered at the active zone (Figure 30). 
 
Figure 30. Graphical representation of a possible mechanistic model describing the results obtained in Figure 29. P/Q-type calcium 
channels diffuse in the area outside the ROI of colocalization and for this reason the integrated intensity colocalizing with bassoon 






6.6 PRRT2-dependent modulation of the presynaptic calcium signal 
 
To determine whether the reduction in presynaptic expression of 
Cav2.1 was accompanied by changes in the presynaptic Ca2+ 
transients of PRRT2 silenced neurons, we used a highly sensitive 
calcium indicator SyGCaMP6s, that allows to specifically measure 
presynaptic Ca2+ transients thanks to its targeting to the presynaptic 
protein, synaptophysin (Thalhammer et al., 2017). 
GCaMP is one of the most widely used genetically encoded calcium 
indicators. GCaMP is developed by fusing a circularly permuted 
variant of enhanced green fluorescent protein (cpEGFP) with the 
calcium-binding protein calmodulin (CaM) at the C terminus and a 
CaM-binding M13 peptide (from myosin light chain) at the N 
terminus. 
Upon Ca2+ binding, the CaM moiety of GCaMP interacts with the M13 
peptide, and the resulting CaM-M13 complex undergoes a significant 
structural reorganization, in proximity to the chromophore of cpEGFP 
(JingJin Ding et al., 2014). 
The most recently developed version SyGCaMP6, possesses long-
sought ultra-sensitivity to Ca2+ dynamics and it is available in three 





After various testing in our experimental conditions, we selected the 
SyGCaMP-6s variant, because, despite its highly non-linear behavior, 
it was the most sensitive, enabling us to detect presynaptic Ca2+ 
transients in response to a single AP and  also after partial blockade 
of Ca2+ entry. 
We investigated whether PRRT2 overexpression or KD affected 
presynaptic Ca2+ transients elicited in presynaptic boutons by a train 
of APs (1-50 APs, 40 Hz) (Figure 31A). While PRRT2 overexpression 
significantly increased presynaptic Ca2+ increase in response to 1-50 
APs (Figure 31B), the acute deletion of PRRT2 surprisingly did not 
exert any significant change (Figure 31C). 
The negative result obtained in PRRT2 deficient synapses, could be 
explained taking in consideration that the SyGCaMP-6s variant is 
sensitive to Ca2+ influx through the presynaptic plasma-membrane 
not only of the active zone but of the entire presynaptic membrane.  
Moreover, such Ca2+-probe is also sensitive to calcium-induced 










Figure 31. (A) Sy-GCaMP6s recordings from primary cortical neurons expressing Prrt2 (right, yellow background) or control mRFP (left). 
Representative images of synaptic boutons at peak response to a 8 APs field stimulation (1.5 ms, 60 V @ 40 Hz; maximal projection of 5 
images). Exogenous expression of PRRT2 (B,PRRT2 OVER, DIV13-14) and PRRT2 knock-down (C,SH4, DIV15-16) affected Sy-GCaMP6s 





So, with the aim of investigating in more detail the presynaptic Ca2+ 
increase due to the activation of P/Q-type VGCCs, we studied the 
effect of Aga-IVA on the Ca2+ increase induced by 1-50 APs evoked at 
0.2 Hz (Figure 32A). We observed that the Aga-IVA-insensitive Ca2+ 
signal that remained after Aga-IVA application was larger in PRRT2 
deficient presynaptic boutons (Figure 32B), an effect that is paralleled 
by a significant decrease of the percentage block induced by the 
selective P/Q-type antagonist (Figure 32C). 
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Figure 32. Effect of PRRT2 on presynaptic Calcium transients. (A) Sy-GCaMP6s fluorescence transients elicited by a train of APs (1-50 APs; 
40 Hz) in presynaptic boutons of murine hippocampal cultures tansfected with control (scramble) and PRRT2 knock-down (sh4) constructs. 
Fluorescence transient traces recorded for one field of view are shown before and after application of agatoxin IVA (Aga, 300 nM, 2 min, 
average of 5-15 boutons). Inset: magnification of response to 1 AP stimulation. Top, partial field of view of images taken before (base) and 
at peak response (peak) to 50 APs stimulation. Images are derived from a merge of 20 consecutive images recorded at 15 frames/sec.  (B) 
Summary of Sy-GCaMP6s transients recorded before (baseline) and after application of Aga. (C) Blocking effects of on Syn-GCAMP6s 
transients. Data are shown as mean+/-SEM. Two way ANOVA followed by Bonferroni post-test * p<0.05, ***p<0.001. Knock-down of 


























We have previously shown that PRRT2 is enriched in presynaptic terminals and 
that its silencing decreases the number of synapses and impairs glutamate 
release, thanks to a sharp decrease in release probability and Ca2+ sensitivity. 
Moreover, we observed that the lack of PRRT2 strongly attenuates the increase 
of the eEPSCs amplitude that in WT neurons is normally observed in response to 
the increase of external calcium concentration from 2 to 4 mM (Valente et al., 
2016).  
This effect could be due to an altered expression and function of the synaptic 
calcium sensor, synaptotagmin 1/2, that we have previously demonstrated is a 
direct or indirect PRRT2-interactor (Valente et al., 2016). These results indicate 
that PRRT2 is intimately connected with the Ca2+-sensing machinery and that it 
plays an important role in the final steps of neurotransmitter release. However, 
PRRT2 modulation of the presynaptic calcium influx could be also implicated.  
With the aim of investigating in more detail the altered calcium dependence of 
glutamate release we have studied eEPSCs amplitude evoked at various 
extracellular calcium concentration. The analysis of dose/response curve 
revealed that PRRT2 deletion did not affect the Hill coefficient (n) and affinity 
constant (EC50), while it significantly decreases the maximal eEPSCs amplitude 
activated at higher (4-8 mM) external calcium concentration. Although these 
results demonstrated a clear impairment in the calcium sensitivity of 
neurotransmitter release, it is not possible to state that such effect depends on 
an impaired presynaptic calcium influx. Thus, we added a study of the 
contribution of presynaptic VG-Ca2+ channels to glutamatergic synaptic 
transmission in neurons lacking PRRT2. We observed that the eEPSCs mediated 
by N- and P/Q-type VGCCs were significantly reduced by PRRT2 deletion, 




Therefore, we pharmacologically dissected somatic VG-Ca2+ currents in cultured 
hippocampal neurons, observing that PRRT2 over-expression significantly 
increased N- and P/Q-type calcium currents. On the contrary both acute and 
chronic deletion of PRRT2 exert the opposite effects. These results strongly 
suggested a PRRT2 role in the modulation of the functional expression of N- and 
P/Q-type VGCCs at the plasma membrane.  
Thanks to biotinylation assay we have confirmed that PRRT2 deletion impaired 
P/Q-type VGCCs trafficking to the membrane. Such effect paralleled with P/Q-
type VGCCs accumulation into the cytoplasmic fraction, possibly a consequence 
of the impaired targeting to the membrane.   
Thus, we have performed an immunocytochemistry double staining assay with 
the goal of characterizing the P/Q-type VGCCs targeting to the membrane of the 
presynaptic boutons. Notably, we revealed that in presynaptic terminals lacking 
PRRT2, the P/Q-type VGCCs diffuse around the presynaptic terminal reducing its 
clustering at the active zone.  
In parallel, we investigated presynaptic calcium influx, taking advantage from the 
use of SyGCaMP-6s, an ultra-sensitive fluorescent calcium indicator, selectively 
expressed at the presynaptic boutons (Thalhammer et al., 2017). We observed 
that PRRT2 over-expression increased presynaptic calcium influx, while 
unexpectedly PRRT2 deletion did not exert any significant change. .  
However, when we studied the Aga-IVA-induced reduction of the presynaptic 
calcium signal, a significant decrease of the P/Q-type dependent calcium wave 
was observed in PRRT2-deficient boutons, demonstrating a selective altered 
function and possibly, targeting at the active zone, of the P/Q-type VGCCs, 
known for its crucial role played in the glutamate release process. In summary, 
our results strongly suggests that the P/Q-type mis-targeting faraway the active 
zone, or/and cytoplasmic retention, observed thanks to the 
immunocitochemestry approach (Figure 27), reduced the amount of calcium 
channels strictly associated to the release machinery complex that in turn 
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contributed to the glutamate release probability decrease that with have 





























Our results could be summarized by the graphical mechanistic model shown in 
the figure 31. In WT glutamatergic presynaptic terminals, PRRT2 allows the 
correct trafficking and targeting of N- and P/Q-type channels to the membrane 
and also contributes to their proximal localization to the release machinery 
molecular complex and to synaptotagmins.  
On the contrary the lack of PRRT2 impaired the N- and P/Q-type channels 
trafficking from the cytoplasm to the membrane (Figure 33 (1)) and in parallel 
induced the altered-localization of N- and P/Q-type channels that have already 
targeted the membrane (Figure 33 (2)) but are unable to colocalize near to the 
release machinery molecular complex and the calcium sensors (Syt1/2). 
Such altered N- and P/Q-type calcium channels -targeting at the active zone is 
probably one of the main cause of the impaired neurotransmitter release 





















9. Materials and Methods 
 
Animals 
GAD67-GFP knock-in mice were generated by inserting the cDNA encoding enhanced 
GFP into the GAD67 locus in TT2 embryonic stem cells, as described in Tamamaki N, et 
al. (2003). Heterozygous GAD67-GFP males were mated with wild-type C57BL6/J 
females, and GFP-positive pups were identified at birth through a Dual Fluorescent 
Protein Flashlight (DFP-1, NIGHTSEA, Lexington, MA USA) and confirmed by genotyping, 
performed by PCR with the following primers: TR-1b: GGCACAGCTCTCCCTTCTGTTTGC; 
TR-3:GCTCTCCTTTCGCGTTCCGACAG; TRGFP-8:CTGCTTGTCGGCCATGATATAGACG. All 
animals were provided by our institutional animal breeding facility in accordance with 
the guidelines approved by the local Animal Care Committee of the University of 
Genova. Experiments used 0–2-day-old pups of either sex. PRRT2-KO mice were 
generated by EUCOMM/KOMP using a targeting strategy based on the “knockout-first” 
allele (Skarnes et al. 2011; Michetti, Castroflorio et al. 2017). Mutant animals in a 
C57BL/6 N background were propagated as heterozygous colonies in the IIT SPF facility. 
Genotyping was performed by PCR with primers Prrt2_F: AGGTAGACGGGCATTTGAGC, 
Prrt2_R: CGTGGGGAAGAGGAGACAAC; CAS_R1_Term: TCGTGGTATC GTTATGCGCC, that 
were used to detect the wild type (WT) (Prrt2_F plus Prrt2_R product, 480 bp) and 
mutant (Prrt2_F plus Cas_R1_Term product, 200 bp) PRRT2 alleles and to genotype WT, 
heterozygous, and homozygous mice. The primer Prrt2_F, common to WT and mutant 
PCR, was designed in the intronic sequence between Prrt2 Exon 1 and Exon 2. The 
primers Prrt2_R and Cas_R1_Term were designed in the exon 2 of the PRRT2 gene and 
in the targeting cassette, respectively. Some experiments were done using wild-type 
C57BL6/J mice. All experiments were carried out in accordance with the guidelines 
established by the European Communities Council (Directive 2010/63/EU of 4 March 







Primary hippocampal neurons were prepared from postnatal GAD67-GFP knock-in mice 
(P0–P1), as previously described (Beaudoin GM et al. 2012, Valente et al., 2016). In brief, 
hippocampi were dissociated by enzymatic digestion in 0.25% trypsin for 6 min at 37 °C 
and then triturated with a fire-polished Pasteur pipette (Banker G and Goslin K, 1998). 
No antimitotic drugs were added to prevent glia proliferation. The following solutions 
were used for cell culture preparations: HANKS solution, prepared from HBSS (GIBCO 
14170-088; red) supplemented with 10 mM HEPES, 30 mM D-glucose, 5 μg/ml 
Gentamycin, pH 7.4 with KOH; dissection solution, prepared from HANKS solution 
supplemented with 10% bovine serum albumin and 6mM MgSO4*7H2O. Some Primary 
hippocampal neurons were prepared from C57BL6/N and PRRT2 KO mice. Animals were 
sacrificed by CO2 inhalation, and 17/18-day embryos (E17-18) were removed 
immediately by cesarean section. In brief, hippocampi or cerebral cortices were 
dissociated by enzymatic digestion in 0.125% Trypsin for 20 min at 37°C and then 
triturated with a firepolished Pasteur pipette. No antimitotic drugs were added to 
prevent glia proliferation. Primary hippocampal neurons were plated at low density of 
80 cells/mm2 on 3.5-cm-diameter Petri dishes (Falcon® 35 mm, 353001) treated 
previously for 24 h with poly-L-lysine (0.1 mg/ml; Sigma-Aldrich) in borate buffer (0.1 
M). Autaptic neurons were prepared as described previously (Bekkers and Stevens, 
1991; Chiappalone et al., 2009) with slight modifications. Dissociated neurons were 
plated at very low density (40 cells/mm2) on microdots (40-300 μm in diameter) 
obtained by spraying a mixture of poly-L-lysine (0.1 mg/ml) in borate buffer (0.1 M) on 
petri dishes, previously pretreated with 0.15% agarose. Cells were grown in a culture 
medium consisting of Neurobasal A (Gibco™) supplemented with 2% B-27 (Invitrogen, 
Italy), 1 mM Glutamax, and 5 μg/ml Gentamycin and maintained at 37 °C in a humidified 
incubator with 5% CO2. 
Transduction of Primary Neurons with PRRT2 shRNA and/or Sh- 
OVEREXPRESSED PRRT2 
shRNAs (Scr: GCCGACACTCGTCAGTTTAAA, Sh4: CATGTGGCCTGTCAACATTGT and OVER; 
CATGTGGCCAGTGAATATCGT) were inserted into the pLKO.1-CMV-mCherry plasmid 
expressing either mCherry for the identification of the transfected cells. The PRRT2 Sh-
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OVEREXPRESSED isoforms were subcloned into lentiviral vectors 
743.pCCLsin.PPT.hPGK.GFP.Wpre (a gift from Dr. L. Naldini). Lentiviral vectors encoding 
Sh4, or the Scr control RNAs were used to knock down the endogenous PPRT2 protein in 
hippocampal neurons. Neurons were infected by the addition of lentiviral vectors into 
cell medium at 6 DIVs. After 24 hr, the medium was removed and replaced with fresh 
and conditioned medium (1:1). A multiplicity of infection (MOI) of 5 of the lentivirus was 
used.  
Electrophysiological recordings 
Patch-clamp recordings were performed using a Multiclamp 700B amplifier (Axon 
Instruments, Molecular Devices, Sunnyvale, CA, USA) using an IX71 inverted 
phase/fluorescence (Olympus, Japan). The age of the patched neurons ranged between 
16 and 18 div for Ca2+ current and between 11 and 14 div for eEPSCs. Patch electrodes, 
fabricated from thick borosilicate glasses were pulled and fire-polished to a final 
resistance of 3–5 MΩ. The standard external solution for the Ca2+ current for the whole-
cell experiments was (in mM): 5 BaCl2, 140 NaCl, 1 MgCl2, 10 HEPES (pH7.4); The 
standard internal solution for the Ca2+ current was (in mM): 90 CsCl, 20 TEACl, 10 EGTA, 
10 Glucose, 1 MgCl2, 4 ATP and 15 phosphocreatine to prevent current run-down (pH 
7.4). Voltage-clamp recordings were performed at a holding potential of -70mV. To 
isolate the calcium current were use nifedipine (5uM), a selective blocker of L-Type Ca2+ 
channels, ω-Agatoxin IVA (Peptide institute, Code: 4256-s) a selective blocker of P/Q-
Type Ca2+ channels and ω-Conotoxin GVIA (Peptide institute, Code: 4161-v) a selective 
blocker of N-Type Ca2+ channels. Voltage- clamp recordings of voltage-gated Ca2+ 
currents were acquired at 50 kHz and low-pass filtered at 2 kHz. Data acquisition was 
performed using pCLAMP program (Molecular Devices, LLC) and using PatchMaster 
programs (HEKA Elektronic, Lambrecht, Germany).  
Voltage-clamp recordings of voltage gated Ca2+ currents were performed on 
Hippocampal neurons using external solution for the Ca2+ current supplemented with D-
AP5 (50 μM), CNQX (10 μM), BIC (30 μM) and Tetradotoxin (1mM). Whole-cell family 
Ca2+ currents were evoked by 10 mV steps from -70 to 70 mV. Linear capacity and 
leakage currents were eliminated by P/N leak subtraction procedure with a subpulse of 
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– 100 mV. Blockade of L-type calcium channels was allowed by the use of a selective 
blocker for these channels, Nifedipine (5μM). 
Voltage-clamp recordings for eEPSC currents were performed on Hippocampal neurons 
using Standard external solution containing (in mM): 140 NaCl, 4 KCl, 10 glucose, 10 
HEPES (pH 7.3 with NaOH) supplemented with D-(-)-2-amino-5 phosphonopentanoic 
acid (D-AP5; 50 μM; Tocris, Bristol, UK); This solution was added with 5 type of 
concentrations of CaCl2 and MgCl2, in particular(in mM): Solution 1, 0.5 CaCl2, 3.5 
MgCl2; Solution 2, 1 CaCl2, 3 MgCl2; Solution 3, 2 CaCl2, 2 MgCl2; Solution 4, 4 CaCl2, 0 
MgCl2; Solution 5, 8 CaCl2, 0 MgCl2.  The standard internal solution was (in mM): 126 
KGluconate, 4 NaCl, 1 MgSO4, 0.02 CaCl2, 0.1 BAPTA, 15 Glucose, 5 HEPES, 3 ATP, 0.1 
GTP (pH 7.2 with KOH). All experiments were performed at room temperature (22-24 
°C). Neurons were voltage-clamped at -70 mV. Unclamped action potentials (APs) were 
evoked by a brief depolarization of the cell body to +40 mV for 0.5 ms @ 0.1 Hz. Data 
acquisition was performed using PatchMaster programs (HEKA Elektronic, Lambrecht, 
Germany). 
Analisys.The Ca2+ current density (J) was obtained by dividing the peak inward current by 
the cell  capacitance (pA/pF).  All the electrophysiological data were analyzed using the 
Clampfit software (Molecular Devices, LLC), OriginPro 8 (OriginLab Corp.) and the Prism 
software (GraphPad Software, Inc.). To analyze paired-pulse ratio (PPR), two brief 
depolarizing pulses were applied to autaptic neurons at 50 ms time intervals. For each 
couple of eEPSCs, PPR was calculated as the ratio I2/I1, where I1 and I2 are the 
amplitudes of the eEPSCs evoked by the conditioning and test stimuli, respectively. 
 
Statistical Analysis 
Data are shown as means ± SEM or as box plots, with median (line), second and third 
interquartile ranges (box), and whiskers representing the min and the max values. The F-
test was used to compare variance between two sample groups. To compare two 
normally distributed sample groups, the unpaired Student’s two-tailed t test was used. 
To compare two sample groups that were not normally distributed, the Mann- 
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Whitney’s U test was used. Statistical analysis was carried out using OriginPro-8 
(OriginLab Corp., Northampton, MA, USA) and Prism (GraphPad Software, Inc.) software. 
 
Surface biotinylation 
Cortical neurons from WT or PRRT2 KO mice at 13 DIV were incubated with 1 mg/ml of 
EZ-Link™ Sulfo-NHS-SS-Biotin (Thermo Fisher, Waltham, MA USA) in cold phosphate-
buffered saline (PBS) for 35 min at 4 °C, constantly moving. Free biotin was quenched, 
twice, with 100 mM Tris pH 8 and once with cold PBS to remove biotin excess. Cells 
were then lysed in lysis buffer (150 mM NaCl, 50 mM Tris, 1 mM EDTA and 1 % Triton X-
100) supplemented with protease inhibitor cocktail (Cell Signaling, Danvers, MA, USA). 
Total cell lysates were centrifuged at 10,000 x g at 4 °C for 10 min. The supernatant 
fraction (0.5 mg protein) was incubated with 150 µl of NeutrAvidin-conjugated agarose 
beads for 3 h at 4 °C, and the remaining supernatant was kept as input. After extensive 
washes of the beads, samples were eluted. Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) was performed according to Laemmli (1970) and samples 
were subjected to SDS polyacrylamide gel electrophoresis on 8% polyacrylamide gels 
and blotted onto nitrocellulose membranes (Whatman, Sigma-Aldrich, St. Louis, MO). 
Membranes were blocked for 1 h in 5% non-fat dry milk/Tris-buffered saline (10 mM 
Tris, 150 mM NaCl, pH 8.0) plus 0.1 % Triton X-100 and incubated overnight at 4 °C or for 
2 h at room temperature with the following primary antibodies: anti P/Q-type calcium 
channel (1:500, Cat. No. 152203, Synaptic Systems), anti actin (1:1000 Sigma-Aldrich, St. 
Louis, MO, USA), anti Na+/K+ ATPase (1:2000, Thermo Scientific, Waltham, MA, USA) 
and anti PRRT2 (1:1000, Sigma-Aldrich, St. Louis, MO, USA HPA 014447). 
Immunocytochemistry  
Primary hippocampal neurons (from WT or KO mice, 60 cells/mm2), were fixed at 15 div 
with 4% paraformaldehyde/4% sucrose for 12 min at room temperature and then 
washed with phosphate buffered saline (PBS). Cells were then permeabilized with 
methanol (-20°C; 10 min on ice) followed by 0.2% Triton X-100 for 10 min (Liao et al., 
1999) and blocking  with 5% FBS/0.1% BSA for 30 min in PBS, before their incubation for 
2h with primary antibodies in PBS/5% FBS/0.1% BSA, then washed with PBS and final 
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incubation for 2h with secondary antibodies. For immunofluorescence analysis, neurons 
were immunostained with antibodies rabbit anti-P/Q-type calcium channel (cav1:500, 
Cat. No. 152203, Synaptic Systems) and guinea pig anti-bassoon (1:500 Cat. No. 141004, 
Synaptic Systems). Secondary antibodies were Alexa 488 goat anti-rabbit and Alexa647 
goat anti-guinea pig IgGs (1:1000 in all cases; Cat. No. A11001, and A21450, respectively, 
Invitrogen). Images of cultured neurons were acquired with a Leica SP8 confocal 
microscope using a 63× objective and 1024×1024 pixels (1pixel=0.24 μm). 
Confocal images were analyzed using ImageJ. Each single stack was filtered at the 
maximal fluorescence intensities of stacks were Z-projected. Analysis of fluorescence 
intensity was performed on axonal ROIs (2-3 per image) of ≈60 μm in lengths and 
somatic ROIs (1-2 per image) of ≈300 μm2 in  manually selected blind to the 
experimental condition. 
The intensity of each ROIs has been calculated as the average intensity divide to the 
integrated intensity of each synapses that circumscribes the Cav2.1 and Bassoon 
positive synaptic signal. The synaptic densities were obtained by counting the total 
number of positive puncta divided by the Area (on Somas in μm2) or lenght (on 
dendrites in μm) of the colocalizated segment. Colocalization between bassoon and 
Cav2.1 was estimated for the thresholded ROIs with the Coloc2 plugin using the 
Manders’ coefficients (MA=Σ𝑖 𝐴i,coloc/Σ𝑖 𝐴i, where Σ𝑖 𝐴i is the sum of intensities of all 
pixels above threshold for channel A and Σ𝑖 𝐴i,coloc is calculated as Σ𝑖 𝐴i but only for 
pixels where also the second channel B is above threshold). The number of samples (n) 
represents the number of coverslips from at least three neuronal preparations 
conducted in parallel. From each coverslip, at least 10–15 images were collected. 
Presynaptic Ca2+ imaging with SyGCaMP6s 
Imaging was performed in murine primary cultures at room temperature in aCSF 
containing (in mM): 140 NaCl, 2.5 KCl,2.2 CaCl2, 1.5 MgCl2, 10 D-glucose, 0.01 CNQX, 
0.05 D-APV and 10 HEPES-NaOH (pH 7.38; osmolarity adjusted to 310 mOsm). Cultures 
were cotransfected with SyGCaMP6s, the auxiliary subunit β4 and the respective control 
and PRRT2 KD constructs in a 1:1:1 DNA ratio 5-6 days prior to experiments, and 
measured at 15-16 DIV. prior to experiments, and measured at 16-18 DIV. Boutons were 
imaged using a cooled charge-coupled device (CCD) camera (ORCA-R2, Hamamatsu) 
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mounted on an inverted microscope (DMI6000B, Leica) with a 40x, 1.25 NA oil 
immersion objective. A 200W metal halide lamp (Lumen200Pro, Prior Scientific) and a 
filter set comprising a BP 470/40 nm excitation filter, a 500 nm dichroic mirror and a BP 
525/50 emission filter (Leica) were used for illumination. Images were captured at 15.3 
Hz with 50 
ms integration times at a depth of 8 bits. APs were evoked by field stimulation (60 V, 1 
ms pulses; Isolated Pulse Stimulator, A-M systems) using a custom-made chamber with 
two parallel platinum wires 6 mm apart. Trains of APs were delivered at a frequency of 
40 Hz every 18 s. Images were analyzed in ImageJ (http://rsb.info.nih.gov/ij) with the 
plugin Time Series Analyzer V2.0 (http://rsb.info.nih.gov/ij/plugins/time-series.html) and 
with customized routines in Igor Pro 6.03. Regions of interest (ROIs) with a diameter of 
3.2 μm were positioned on all boutons responding to 20 APs for SyGCaMP6s with a 
signal above two SD of the background noise. The intensity of a twin ROI positioned 
within 10 μm from the first was used to subtract the local background noise. Signals 
















10. List of abbreviations 
 
PKD = Paroxysmal kinesigenic dyskinesia  
PRRT2 = Proline-rich transmembrane protein 2 
ICCA = Infantile convulsions with choreoathetosis 
DIV = Days in vitro 
SNAP-25 = Synaptosomal-associated protein 25 
NSF = N-ethylmaleimide sensitive factor 
SNARE = Soluble N-ethylmaleimide-sensitive fusion protein attachment protein 
receptors 
SVs = Synaptic vesicles 
AMPA = α-amino-3-hydroxy-5-methyl-4-isoxazolepro-pionic acid 
IC = Infantile convulsions 
BFIS = Benign familial infantile seizures 
PNKD = Paroxysmal non-kinesigenic dyskinesia 
EA = Episodic ataxia 
PED = Paroxysmal exercise induced dyskinesia 
HM = Hemiplegic migraine 
FS = Febrile seizures 
CAE = Childhood-absence epilepsy 
PSD = Postsynaptic density 
NSSP = Non- synaptic synaptosomal protein 
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GRIA = GluA1 subunit 
AZ = Active Zone 
PSCs = Postsynaptic currents 
mEPSCs = Miniature excitatory postsynaptic currents 
eEPSCs = Evoked excitatory postsynaptic current 
PPR = Paired-pulse ratio 
RRP = Readily releasable pool 
GABAA = Gamma-aminobutyric acid receptor type A 
GPCRs = G-protein-coupled receptors 
Syt = Synaptotagmins 
GPCRs = G-protein-coupled receptors 
VGCCs = Voltage-gated calcium channels 
CamKII = Ca2+/calmodulin-dependent protein kinase type II 
GAD67 = Glutamic acid decarboxylase-67 
GFAP = Glial fibrillary acidic protein 
VGLUT1 = Vesicular glutamate transporter-1 
VGAT = Vesicular GABA transporter 
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Hippocampal Excitatory and Inhibitory Neurons. Mol Neurobiol. (2019) 
56(9):6276-6292.  
Cosimo Prestigio, Daniele Ferrante., Pierluigi Valente, Silvia Casagrande, 
Ennio Albanesi, Yuchio Yanagawa, Fabio Benfenati, Pietro Baldelli.  
Abstract: Cultured hippocampal neurons represent the most widely used 
experimental substrate for in vitro electrophysiological studies. 
Nevertheless, in most cases, the nature of neuron under study is not 
identified as excitatory or inhibitory, or even worse, recorded neurons 
are considered as excitatory because of the paucity of GABAergic 
interneurons. Thus, the definition of reliable criteria able to guarantee an 
unequivocal identification of excitatory and inhibitory cultured 
hippocampal neurons is an unmet need. To reach this goal, we compared 
the electrophysiological properties and the localization and size of the 
axon initial segment (AIS) of cultured hippocampal neurons, taking 
advantage from GAD67- GFP knock-in mice, which expressing green 
fluorescent protein (GFP) in gamma- aminobutyric acid (GABA)-containing 
cells, allowed to unambiguously determine the precise nature of the 
neuron under study. Our results demonstrate that the passive 
electrophysiological properties, the localization and size of the AIS, and 
the shape and frequency of the action potential (AP) are not reliable to 
unequivocally identify neurons as excitatory or inhibitory. The only 
parameter, related to the shape of the single AP, showing minimal 
overlap between the sample-point distributions of the two neuronal 
subpopulations, was the AP half-width. However, the estimation of the 
AP failure ratio evoked by a short train of high-current steps applied at 
increasing frequency (40-140 Hz) resulted to be indisputably the safer and 
faster way to identify the excitatory or inhibitory nature of an unknown 
neuron. Our findings provide a precise framework for further 
electrophysiological investigations of in vitro hippocampal neurons.  
• TBC1D24 regulates axonal outgrowth and membrane trafficking at the 
growth cone in rodent and human neurons. Cell Death & Differentiation 
(2019) 26, pages2464–2478 
93 
 
Davide Aprile, Floriana Fruscione, Simona Baldassari, Manuela Fadda, 
Daniele Ferrante, Antonio Falace, Emmanuelle Buhler, Jacopo Sartorelli, 
Alfonso Represa, Pietro Baldelli, Fabio Benfenati, Federico Zara, Anna 
Fassio  
Abstract: Mutations in TBC1D24 are described in patients with a 
spectrum of neurological diseases, including mild and severe epilepsies 
and complex syndromic phenotypes such as Deafness, Onycodystrophy, 
Osteodystrophy, Mental Retardation and Seizure (DOORS) syndrome. The 
product of TBC1D24 is a multifunctional protein involved in neuronal 
development, regulation of synaptic vesicle trafficking, and protection 
from oxidative stress. Although pathogenic mutations in TBC1D24 span 
the entire coding sequence, no clear genotype/phenotype correlations 
have emerged. However most patients bearing predicted loss of function 
mutations exhibit a severe neurodevelopmental disorder. Aim of the 
study is to investigate the impact of TBC1D24 knockdown during the first 
stages of neuronal differentiation when axonal specification and 
outgrowth take place. In rat cortical primary neurons silenced for 
TBC1D24, we found defects in axonal specification, the maturation of 
axonal initial segment and action potential firing. The axonal phenotype 
was accompanied by an impairment of endocytosis at the growth cone 
and an altered activation of the TBC1D24 molecular partner ADP 
ribosylation factor 6. Accordingly, acute knockdown of TBC1D24 in 
cerebrocortical neurons in vivo analogously impairs callosal projections. 
The axonal defect was also investigated in human induced pluripotent 
stem cell-derived neurons from patients carrying TBC1D24 mutations. 
Reprogrammed neurons from a patient with severe developmental 
encephalopathy show significant axon formation defect that were absent 
from reprogrammed neurons of a patient with mild early onset epilepsy. 
Our data reveal that alterations of membrane trafficking at the growth 
cone induced by TBC1D24 loss of function cause axonal and excitability 
defects. The axonal phenotype correlates with the disease severity and 
highlight an important role for TBC1D24 in connectivity during brain 
development. 
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